Commission Regulation (EC) No 1451/2007 of 4 December 2007 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market (Text with EEA relevance)
Modified by
  • Commission Regulation (EU) No 298/2010of 9 April 2010amending Regulation (EC) No 1451/2007 as regards the extension of the duration of derogations allowing the placing of biocidal products on the market(Text with EEA relevance), 32010R0298, April 10, 2010
  • Commission Regulation (EU) No 613/2013of 25 June 2013amending Regulation (EC) No 1451/2007 as regards additional active substances of biocidal products to be examined under the review programme, 32013R0613, June 26, 2013
  • Commission Delegated Regulation (EU) No 1062/2014of 4 August 2014on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council(Text with EEA relevance), 32014R1062, October 10, 2014
Commission Regulation (EC) No 1451/2007of 4 December 2007on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market(Text with EEA relevance)
Article 1Subject matterThis Regulation lays down detailed rules for the implementation of the programme of work for the systematic examination of all active substances already on the market on 14 May 2000 as active substances of biocidal products, hereinafter "the review programme", referred to in Article 16(2) of Directive 98/8/EC.
Article 2DefinitionsFor the purposes of this Regulation the definitions in Article 2 of Directive 98/8/EC and Article 2 of Regulation (EC) No 1896/2000 shall apply.In addition, "participant" means a person which has submitted a notification that has been accepted by the Commission in accordance with Article 4(2) of Regulation (EC) No 1896/2000 or with Article 3c(1) of this Regulation, or a Member State which has indicated an interest in accordance with Article 5(3) of Regulation (EC) No 1896/2000.
Article 3Existing active substances1.The list of active substances identified as available on the market before 14 May 2000 as active substances of biocidal products for purposes other than those referred to in Article 2(2)(c) and (d) of Directive 98/8/EC is set out in Annex I.2.The exhaustive list of existing active substances to be examined under the review programme is set out in Annex II.The list includes the following active substances:(a)existing active substances notified in accordance with Article 4(1) of Regulation (EC) No 1896/2000 or Article 4(2) of Commission Regulation (EC) No 1687/2002OJ L 258, 26.9.2002, p. 15.;(b)existing active substances that were not notified, but in respect of which a Member State has indicated an interest in supporting their inclusion in Annex I, IA or IB to Directive 98/8/EC;(c)existing active substances that were not notified, but for which a dossier was submitted to one of the Member States by 1 March 2006, which was found to comply with the requirements of Annex III to this Regulation and was accepted as complete;(d)existing active substances notified in accordance with Article 3b.The list specifies, for each existing active substance included, the product types in respect of which the substance will be examined under the review programme, as well as the Rapporteur Member State designated to carry out the evaluation.
Article 3aProcedure for the declaration of intention to notify1.A person or a Member State considering that a biocidal product being placed on the market and containing only existing active substances is covered by Directive 98/8/EC and falls under one or more product-types for which Article 4 prohibits the placing on the market may submit a request to the Commission to allow the notification of the active substances contained in that product for the relevant product-types.The request shall indicate the relevant active substance/product-type combinations, and a justification for the failure to submit a notification in accordance with Article 4(1) of Regulation (EC) No 1896/2000, or to indicate an interest in accordance with Article 5(3) of that Regulation, or to take over the role of participant in accordance with Article 12 of this Regulation, or to submit a complete dossier in accordance with Article 9(1) of this Regulation.2.Upon receipt of a request in accordance with paragraph 1, the Commission shall consult Member States on whether the request is acceptable.The request shall be acceptable if the biocidal product is covered by Directive 98/8/EC and falls under one or more product-types for which Article 4 of this Regulation prohibits the placing on the market and, prior to submitting that request, the applicant held an objectively justified belief, induced by guidance published or written advice given by the Commission or by a competent authority designated in accordance with Article 26 of Directive 98/8/EC, that the product was excluded from the scope of Directive 98/8/EC or that it fell under a different product-type.However, the request shall not be acceptable if the active substance/product-type combination concerned has already been the subject of a decision not to include it in Annex I or IA to Directive 98/8/EC based on an assessment report reviewed by the Standing Committee on Biocidal Products in accordance with Article 15(4) of this Regulation.3.Where, following a consultation in accordance with paragraph 2, the Commission finds the request acceptable, it shall accept it and allow the notification of the active substance for the relevant product-types.However, where the dossier submitted to the Rapporteur Member State for the relevant active substance already contains all the data required for the evaluation of the relevant product-types for which Article 4 prohibits the placing on the market, and the participant which has submitted that dossier wishes to be considered as having notified the active substance for those product-types, the Rapporteur Member State shall inform the Commission thereof, and no additional notification shall be allowed pursuant to the first subparagraph.The Commission shall inform the Member States thereof and publish that information electronically.4.A person intending to notify the active substance/product-type combination included in the electronic publication referred to in the third subparagraph of paragraph 3 shall declare that intention to the Commission no later than three months from the date of that electronic publication.
Article 3bNotification procedure1.Following the declaration of intention to notify, the person referred to in Article 3a(4) shall submit a notification of the active substance/product-type combination to the European Chemicals Agency established by Regulation (EC) No 1907/2006 (hereinafter referred to as the "Agency") no later than 18 months from the date of the electronic publication referred to in the third subparagraph of Article 3a(3).The notification shall be made through the Register for Biocidal Products referred to in Article 71 of Regulation (EU) No 528/2012 of the European Parliament and of the CouncilOJ L 167, 27.6.2012, p. 1..2.The notification shall be submitted in IUCLID format. It shall contain all the information referred to in points 1 to 3 and the table in Annex II to Regulation (EC) No 1896/2000, and proof that the substance was on the market as an active substance of a biocidal product falling under the relevant product-type on the date of the electronic publication referred to in the third subparagraph of Article 3a(3).3.Unless a Rapporteur Member State has already been designated for the active substance in question, the notifier shall indicate to which competent authority of a Member State it intends to submit a dossier, and provide written confirmation that that competent authority agrees to evaluate the dossier.4.Upon receipt of a notification, the Agency shall inform the Commission thereof, and inform the notifier of the fees payable under the Regulation adopted pursuant to Article 80(1) of Regulation (EU) No 528/2012. If the notifier fails to pay the fee within 30 days from the receipt of that information, the Agency shall reject the notification and inform the notifier thereof.5.Upon receipt of payment of the fees, the Agency shall verify within 30 days whether the notification complies with the requirements of paragraph 2. If the notification does not comply with those requirements, the Agency shall grant the notifier a period of 30 days in which to complete or correct the notification. After the expiry of that 30-day period, the Agency shall, within 30 days, either declare that the notification complies with the requirements of paragraph 2 or reject the notification, and inform the notifier thereof.6.Appeals against decisions of the Agency taken pursuant to paragraph 4 or paragraph 5 shall lie with the Board of Appeal established by Regulation (EC) No 1907/2006. Article 92(1) and (2), and Articles 93 and 94 of Regulation (EC) No 1907/2006 shall apply to such appeal procedures. An appeal shall have suspensive effect.7.The Agency shall without delay inform the Commission of whether the notification complies with the requirements of paragraph 2 or has been rejected.
Article 3cInclusion in, or exclusion from, the review programme1.Where an active substance is considered notified in accordance with the second subparagraph of Article 3a(3), or where the Agency informs the Commission in accordance with Article 3b(7) that a notification complies with the requirements of Article 3b(2), the Commission shall accept the notification and:(a)where the active substance/product-type combination concerned is not included in Annex II to this Regulation, include the active substance/product-type combination therein and, where relevant, the active substance in Annex I to this Regulation;(b)where the active substance/product-type combination concerned is included in Annex II to this Regulation but has been the subject of a Commission decision not to include it in Annex I or IA of Directive 98/8/EC, annul that decision.2.Where a declaration of intention to notify has not been received within the deadline referred to in Article 3a(4), where a notification has not been received within the deadline referred to in Article 3b(1), or where the Agency informs the Commission in accordance with Article 3b(7) that a notification submitted in accordance with Article 3b(1) has been rejected, the Commission shall inform the Member States thereof and publish that information electronically.
Article 4Non-inclusion1.Without prejudice to Articles 5 and 6 of this Regulation and paragraph 2 of this Article, biocidal products containing active substances not listed in Annex II to this Regulation or in Annex I or IA to Directive 98/8/EC shall no longer be placed on the market.In the case of an active substance listed in Annex II to this Regulation, the first subparagraph shall also apply to that substance in relation to any product type not listed in that Annex.2.Biocidal products containing active substances listed in Annex II to this Regulation for which a decision was taken not to include these active substances for certain or all of their notified product types in Annex I or IA to Directive 98/8/EC, shall no longer be placed on the market for the product types concerned, with effect from 12 months after the date of such a measure being published, unless otherwise stipulated therein.3.Without prejudice to Articles 12(1)(b) and 15(2) of Directive 98/8/EC, from the day of entry into force of this Regulation, any active substance not listed in Annex I shall be deemed not to have been placed on the market for biocidal purposes before 14 May 2000.4.By way of derogation from paragraphs 1 and 2, biocidal products containing an active substance for which the Commission has published electronically the relevant information in accordance with the third subparagraph of Article 3a(3) for the relevant product-types may be placed on the market in accordance with Article 16(1) of Directive 98/8/EC until the date when the Commission has taken a decision to include the active substance/product-type combination in Annex II in accordance with point (a) of Article 3c(1) or to annul a previous non-inclusion decision in accordance with point (b) of Article 3c(1), or for a period of six months from the date when the Commission has published electronically the relevant information in accordance with Article 3c(2).
Article 5Derogation for essential use1.Member States may apply to the Commission for a derogation from Article 4(1) where they consider that an active substance is essential for them for reasons of health, safety or protection of cultural heritage or is critical for the functioning of society, and where there are no available technically and economically feasible alternatives or substitutes that are acceptable from the standpoint of environment and health.Applications shall be accompanied by a document stating the reasons and justifications.2.The applications referred to in paragraph 1 shall be forwarded by the Commission to the other Member States and shall be made publicly available by electronic means.Member States or any person may for a period of 60 days following reception of an application submit comments in writing to the Commission.3.Taking account of the comments received, the Commission may grant a derogation from Article 4(1) allowing the placing of the substance on the market of the requesting Member States until the date referred to in the first subparagraph of Article 16(2) of Directive 98/8/EC at the latest, provided that the Member States:(a)ensure that continued use is possible only if products containing the substance are approved for the intended essential use;(b)conclude that, taking into account all available information, it is reasonable to assume that continued use does not have any unacceptable effect on human or animal health or on the environment;(c)impose all appropriate risk reduction measures when granting approval;(d)ensure that such approved biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the use conditions laid down by the Member States in accordance with this paragraph; and(e)ensure that, where appropriate, alternatives for such uses are being sought by the holders of the approvals or the Member States concerned, or a dossier is being prepared for submission in accordance with the procedure laid down in Article 11 of Directive 98/8/EC at the latest two years before the date referred to in the first subparagraph of Article 16(2) of Directive 98/8/EC.4.The Member States concerned shall annually inform the Commission on the application of paragraph 3 and in particular on the actions taken pursuant to point (e).5.Member States may at any time review the approvals of biocidal products for which the period of placing on the market has been extended in accordance with paragraph 3. Whenever there is reason to believe that any of the conditions set in points (a) to (e) of that paragraph are no longer satisfied, the Member States concerned shall without undue delay take steps to remedy the situation or if that is not possible, withdraw the approvals of the biocidal products concerned.
Article 6Food and FeedBy way of derogation from Article 4(1), Member States may allow until the date referred to in the first subparagraph of Article 16(2) of Directive 98/8/EC at the latest the placing on the market of active substances consisting solely of food or feed that are intended for use as repellents or attractants of product type 19.For the purposes of this derogation, "food or feed" means any edible substance or product of plant or animal origin, whether processed, partially processed or unprocessed, which is intended or reasonably expected to be ingested by humans or animals; this category does not comprise extracts or individual substances isolated from food or feed.
Article 7Examination of existing active substances under the review programme1.The review of an active substance listed in Annex II, in respect of the product types specified, shall be undertaken by the Rapporteur Member State designated for that purpose on the basis of the complete dossier for that substance/product type combination, provided that:(a)the dossier complies with the requirements set out in Annex III to this Regulation;(b)the complete dossier is submitted within the period specified in Article 9 of this Regulation for the product type concerned, together with the summary dossier referred to in Article 11(1)(b) of Directive 98/8/EC and defined in Annex III to this Regulation.An active substance listed in Annex II to this Regulation shall be reviewed exclusively in relation to the product types specified therein.For the active substance/product type combinations referred to in Article 3(2)(c), with the exception of product types 8 and 14, the evaluation of the dossiers shall commence at the same time as the evaluation of dossiers for active substances contained in the same product types.2.A Member State which has indicated an interest in supporting the inclusion of an active substance in Annex I, IA or IB to the Directive shall not be designated as Rapporteur Member State in respect of that substance.3.Without prejudice to Articles 10, 11 and 12 of this Regulation, persons other than participants may apply, in accordance with Article 11 of Directive 98/8/EC, for the inclusion in Annex I, IA or IB thereto of an existing active substance/product type combination that is listed in Annex II to this Regulation. These persons shall submit in that case a complete dossier within the time period specified in Article 9 for that substance/product type combination.
Article 8Preparation of the complete dossier1.In the preparation of the complete dossier, all reasonable efforts shall be made, inter alia, to avoid duplication of testing on vertebrate animals and, where appropriate, to establish a collective complete dossier.2.Before commencing compilation of the complete dossier, a participant shall:(a)inform the Rapporteur Member State of any testing on vertebrate animals that it has already carried out;(b)contact the Rapporteur Member State for advice as to the acceptability of justifications for waiving certain studies;(c)inform the Rapporteur Member State of any intention to carry out further testing on vertebrate animals for the purposes of the complete dossier;(d)when informed by the Rapporteur Member State that another participant has notified plans to carry out the same tests, make all reasonable efforts to cooperate with that participant in the performance of common testing.Advice given by Rapporteur Member States in accordance with point (b) of the first subparagraph shall not predetermine the outcome of the completeness check under Article 13(1).3.A Rapporteur Member State may make available the reference to any test carried out on vertebrate animals in respect of an active substance listed in Annex II to this Regulation, save where that reference is to be treated as confidential in accordance with Article 19 of Directive 98/8/EC. Such reference may include the name of the active substance concerned, the end points of the tests, and the contact address of the data owner.4.Where a Rapporteur Member State is aware that more than one participant is seeking review of a particular active substance, it shall inform those participants accordingly.5.Participants seeking review of the same active substance for the same product types shall undertake all reasonable efforts to submit a collective complete dossier, while fully respecting the Community rules on competition.Where, in those circumstances, a collective dossier is not submitted, each individual dossier shall detail the efforts made to secure cooperation and the reasons for non-participation.6.Details shall be given in the complete dossier and in the summary dossier of the efforts made to avoid duplication of testing on vertebrate animals.7.In order to provide information on the costs entailed in applying for review and on the need for animal testing for the purposes of compiling the complete dossier, participants may submit to the Rapporteur Member State together with the complete dossiers a breakdown of the costs of the respective actions and studies carried out.The Rapporteur Member State shall communicate that information to the Commission when submitting the competent authority report in accordance with Article 14(4).8.Information on the costs entailed in compiling the complete dossier and on the animal testing carried out for that purpose shall be included in the report referred to in Article 18(5) of Directive 98/8/EC together with any appropriate recommendations concerning modifications of data requirements in order to reduce to a minimum the need for testing on vertebrate animals, and to ensure cost-effectiveness and proportionality.
Article 9Submission of the complete dossier1.Unless otherwise indicated by the Rapporteur Member State, a participant shall submit to the Rapporteur Member State one paper and one electronic copy of the complete dossier.The participant shall also, in accordance with Article 13(3), submit one paper and one electronic copy of the summary dossier to the Commission and to each of the other Member States. However, any Member State wishing to receive copies only in electronic format or additional copies shall inform the Commission, which shall make that information publicly available by electronic means. If the Member State subsequently decides otherwise, it shall inform the Commission without undue delay, whereupon the Commission shall update accordingly the information made publicly available.2.For the existing active substances listed in Annex II, complete dossiers must be received by the competent authority of the Rapporteur Member State within the following periods:(a)for product types 8 and 14, until 28 March 2004;(b)for product types 16, 18, 19 and 21, from 1 November 2005 until 30 April 2006;(c)for product types 1, 2, 3, 4, 5, 6 and 13, from 1 February 2007 until 31 July 2007;(d)for product types 7, 9, 10, 11, 12, 15, 17, 20, 22 and 23, from 1 May 2008 until 31 October 2008.3.By way of derogation from paragraph 2, for active substance/product-type combinations listed in Annex II in accordance with point (a) of Article 3c(1), or for which a decision has been annulled in accordance with point (b) of Article 3c(1), applications for approval of an active substance in accordance with Article 7 of Regulation (EU) No 528/2012 shall be submitted no later than two years from the date of the decision adopted in accordance with points (a) or (b) of Article 3c(1).
Article 10Joining and replacing of participantsWhere, by mutual agreement, a producer, formulator or association joins or replaces a participant for the purposes of submitting the complete dossier, all parties to the agreement shall jointly inform the Commission and the Rapporteur Member State accordingly, attaching any relevant letter of access.The Commission shall inform accordingly any other participant seeking review of the same active substance in relation to the same product types.
Article 11Withdrawal of participants1.Where a participant intends to discontinue participation in the review programme, they shall inform the relevant Rapporteur Member State and the Commission accordingly, in writing and without delay, stating the reasons.The Commission shall inform accordingly the other Member States and any other participant seeking review of the same active substance in relation to the same product type(s).2.Where all the participants have withdrawn as regards a particular existing active substance/product type combination, the Commission shall inform the Member States thereof and shall publish that information electronically.
Article 12Taking over the role of participant1.Within three months of the electronic publication of the information referred to in Article 11(2), a producer, formulator, association or other person may inform the Commission of their intention to take over the role of participant as regards the existing active substance/product type combination.Within the time period referred to in the first subparagraph, a Member State may also indicate to the Commission an interest in taking over the role of participant in order to support the inclusion in Annex I, IA or IB to Directive 98/8/EC of the existing active substance/product type combination, where there are uses which the Member State considers essential, in particular for the protection of human health, animal health or the environment.2.The person or Member State wishing to take over the role of the participant who has withdrawn shall, within three months of informing the Commission of their intention, provide evidence to it that work to compile a complete dossier has been commissioned.3.On the basis of the evidence referred to in paragraph 2, the Commission shall decide whether or not to allow the interested person or Member State to take over the role of participant.Where the Commission allows the interested person or Member State to take over the role of participant, it may decide to extend, if necessary, the relevant period for the submission of a complete dossier specified in Article 9.4.The taking over of the role of participant for a given existing active substance/product type combination may be allowed only once.5.Where the Commission receives no response pursuant to paragraph 1, it shall take a decision not to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC within the framework of the review programme for the product type(s) concerned.
Article 13Completeness check of dossiers1.Within three months of receiving the dossier for an existing active substance/product type combination and no later than three months after the end of the relevant time period specified in Article 9(2) of this Regulation, the Rapporteur Member State shall verify whether the dossier is to be accepted as complete in accordance with Article 11(1)(b) of Directive 98/8/EC.Where the Rapporteur Member State has initiated consultations with other Member States and the Commission in relation to the acceptability of a dossier, the period may be prolonged until consultations have been finalised, up to a maximum of six months from receipt of the dossier.2.A Rapporteur Member State may require, as a condition for considering a dossier to be complete, proof of advance payment, in full or in part, of the charges payable under Article 25 of Directive 98/8/EC to be provided in the dossier.3.Where a dossier is considered to be complete, the Rapporteur Member State shall confirm acceptance of the dossier to the participant and agree to the participant forwarding the summary dossier to the Commission and the other Member States within one month of receiving the confirmation.If a Member State in receipt of a summary dossier has legitimate reason to believe that the dossier is incomplete, it shall without delay communicate its concerns to the Rapporteur Member State, the Commission and the other Member States.The Rapporteur Member State shall immediately take up consultations with that Member State and the Commission in order to discuss the concern expressed and resolve divergent opinions.4.In exceptional circumstances, the Rapporteur Member State may establish a new deadline for the submission of information which, for reasons duly substantiated, the participant was unable to submit in due time.The participant shall, within three months of being informed of the new deadline, provide evidence to the Rapporteur Member State that work to provide the missing information has been commissioned.If the Rapporteur Member State considers that it has received sufficient evidence, it shall carry out its evaluation in accordance with Article 14 as if the dossier were complete. Otherwise, the evaluation shall not commence until the missing information is submitted.5.Where a complete dossier is not received within the period specified in Article 9 or by a new deadline established in accordance with paragraph 4, the Rapporteur Member State shall inform the Commission, giving the reasons put forward by the participant by way of justification.The Rapporteur Member State shall also inform the Commission in cases where a participant fails to provide the evidence required in accordance with the second subparagraph of paragraph 4. In the cases referred to in the first and second subparagraphs and if no other dossier concerns the same existing active substance/product type combination, all participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis.
Article 14Evaluation of dossiers by the Rapporteur Member State1.Where the Rapporteur Member State considers a dossier to be complete, it shall carry out the evaluation within twelve months of accepting the dossier in accordance with Article 11(2) of Directive 98/8/EC and shall prepare a report on that evaluation, hereinafter "the competent authority report".Without prejudice to Article 12 of Directive 98/8/EC, the Rapporteur Member State may take into account other relevant technical or scientific information regarding the properties of the active substance, metabolites or residues.2.At the request of a participant, the Rapporteur Member State may take into account additional information relating to an active substance for which the dossier has been accepted as complete only if the following conditions are fulfilled:(a)the participant informed the Rapporteur Member State, at the time of submission of the dossier, that preparation of the additional information was under way;(b)the additional information is submitted no later than nine months after acceptance of the dossier in accordance with Article 13(3);(c)by comparison with the data originally submitted, the additional information is equally or more reliable owing to the application of the same or higher quality standards;(d)by comparison with the data originally submitted, the additional information supports a different conclusion concerning the active substance for the purposes of the recommendation under paragraph 6.The Rapporteur Member State shall take into account additional information submitted by persons other than the participant only if that information satisfies the conditions set out in points (b), (c) and (d) of the first subparagraph.3.Where relevant in the application of paragraph 1, in particular when additional information has been requested by a deadline established by the Rapporteur Member State, the latter may request that the participant submit updated summary dossiers to the Commission and the other Member States when the additional information is received.All participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis if:(a)the additional information is not received by the deadline;(b)the participant fails to provide adequate justification for further postponing the deadline;(c)no other dossier concerns the same existing active substance/product type combination.4.The Rapporteur Member State shall, without undue delay, send a copy of the competent authority report to the Commission, the other Member States and to the participant.5.A Rapporteur Member State may decide to withhold the competent authority report if the charges payable under Article 25 of Directive 98/8/EC have not been paid in full, in which case it shall inform the participant and the Commission accordingly.All participants shall be deemed to have withdrawn and Articles 11(2) and 12 shall apply mutatis mutandis if:(a)full payment is not received within three months of the date of receipt of that information;(b)no other dossier concerns the same existing active substance/product type combination.6.The competent authority report shall be presented in a format to be recommended by the Commission and shall include one of the following:(a)a recommendation to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC, stating, where appropriate, conditions for inclusion;(b)a recommendation not to include the existing active substance in Annex I, IA or IB to Directive 98/8/EC, stating the reasons.
Article 15Commission procedures1.When the Commission receives a competent authority report pursuant to Article 14(4) of this Regulation it shall, without undue delay, prepare the draft decision referred to in Article 27 of Directive 98/8/EC.2.Before preparing the draft decision referred to in paragraph 1, the Commission shall, when necessary in the light of the comments received on the competent authority report, consult with experts from the Member States to address any problems remaining unresolved. Where necessary and upon a request from the Commission, the Rapporteur Member State shall prepare an updated competent authority report.3.Where an existing active substance, despite a recommendation for inclusion pursuant to Article 14(6) of this Regulation, still gives rise to concern, as referred to in Article 10(5) of Directive 98/8/EC, the Commission may, without prejudice to Article 12 of that Directive, take into account the finalisation of the evaluation of other existing active substances applied for the same use.4.On the basis of the documents and information referred to in Article 27(2) of Directive 98/8/EC, the Rapporteur Member State shall prepare an updated competent authority report, the first part of which shall form the assessment report. The assessment report shall be reviewed within the Standing Committee on Biocidal Products. Where several dossiers have been submitted for the same active substance/product type combination, the Rapporteur Member State shall prepare one assessment report based on the information contained in those dossiers.
Article 16Access to informationWhere a Rapporteur Member State has submitted the competent authority report in accordance with Article 14(4) of this Regulation, or where an assessment report has been finalised or updated in the Standing Committee on Biocidal Products, the Commission shall make the report or any updates thereof publicly available by electronic means, except for information that is to be treated as confidential in accordance with Article 19 of Directive 98/8/EC.
Article 17Suspension of proceduresWhere, in respect of an active substance listed in Annex II to this Regulation, the Commission presents a proposal for amending Directive 76/769/EEC or, with effect from 1 June 2009, Annex XVII of Regulation (EC) No 1907/2006 in order to prohibit its placing on the market or its use, including use for biocidal purposes, in certain or all product types, the procedures provided for in this Regulation concerning that substance for use in the product types concerned may be suspended pending a decision on that proposal.
Article 18RepealRegulation (EC) No 2032/2003 is repealed.References to the repealed Regulation shall be construed as references to this Regulation.
Article 19Entry into forceThis Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.ANNEX I
ACTIVE SUBSTANCES IDENTIFIED AS EXISTINGThis substance also has a different CAS number (31654-77-0) according to the ESIS registry.
Name (EINECS and/or others)EC numberCAS number
Formaldehyde200-001-850-00-0
Ergocalciferol/Vitamin D2200-014-950-14-6
Lactic acid200-018-050-21-5
Clofenotane/DDT200-024-350-29-3
Ascorbic acid200-066-250-81-7
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxide200-076-751-03-6
2,4-dinitrophenol200-087-751-28-5
2-imidazol-4-ylethylamine200-100-651-45-6
Bronopol200-143-052-51-7
Trichlorfon200-149-352-68-6
Sodium salicylate200-198-054-21-7
Fenthion200-231-955-38-9
Glycerol trinitrate200-240-855-63-0
Bis(tributyltin) oxide200-268-056-35-9
Tributyltin acetate200-269-656-36-0
Coumaphos200-285-356-72-4
Glycerol200-289-556-81-5
Chlorhexidine diacetate200-302-456-95-1
Allyl isothiocyanate200-309-257-06-7
Cetrimonium bromide/Hexadecyltrimethylammonium bromide200-311-357-09-0
Urea200-315-557-13-6
Strychnine200-319-757-24-9
Propane-1,2-diol200-338-057-55-6
Ethinylestradiol200-342-257-63-6
Caffeine200-362-158-08-2
Diphenoxarsin-10-yl oxide200-377-358-36-6
Gamma-HCH or Gamma-BHC/Lindane/1,2,3,4,5,6-hexachlorocyclohexane200-401-258-89-9
Sulfaquinoxaline200-423-259-40-5
Chlorocresol200-431-659-50-7
2-phenylethanol200-456-260-12-8
Dimethoate200-480-360-51-5
Methylthioninium chloride200-515-261-73-4
Thiourea200-543-562-56-6
Dichlorvos200-547-762-73-7
Carbaryl200-555-063-25-2
Ethanol200-578-664-17-5
Formic acid200-579-164-18-6
Acetic acid200-580-764-19-7
Benzoic acid200-618-265-85-0
Propan-2-ol200-661-767-63-0
Chloroform/Trichloromethane200-663-867-66-3
Colecalciferol200-673-267-97-0
Salicylic acid200-712-369-72-7
Hexachlorophene200-733-870-30-4
Propan-1-ol200-746-971-23-8
Butan-1-ol200-751-671-36-3
Methoxychlor200-779-972-43-5
Bromomethane/Methyl bromide200-813-274-83-9
Hydrogen cyanide200-821-674-90-8
Metaldehyde200-836-89002-91-9
Carbon disulfide200-843-675-15-0
Ethylene oxide200-849-975-21-8
Iodoform/Triiodomethane200-874-575-47-8
Tert-butyl hydroperoxide200-915-775-91-2
Trichloronitromethane200-930-976-06-2
Bornan-2-one/Campher200-945-076-22-2
(3aS,6aR,7aS,8S,11aS,11bS,11cS)-1,3a,4,5,6a,7,7a,8,11,11a,11b,11c-dodecahydro-2,10-dimethoxy-3,8,11a,11c-tetramethyldibenzo[de,g]chromene-1,5,11-trione/Quassin200-985-976-78-8
1,3-dibromo-5,5-dimethylhydantoin201-030-977-48-5
3-beta-hydroxyurs-12-en-28-oic acid/Ursolic acid201-034-077-52-1
Citric acid201-069-177-92-9
Citric acid monohydrate201-069-15949-29-1
1,3,4,5-tetrahydroxycyclohexanecarboxylic acid201-072-877-95-2
Linalool201-134-478-70-6
2-methylpropan-1-ol201-148-078-83-1
2-chloroacetamide201-174-279-07-2
Bromoacetic acid201-175-879-08-3
Propionic acid201-176-379-09-4
Chloroacetic acid201-178-479-11-8
Glycollic acid201-180-579-14-1
Peracetic acid201-186-879-21-0
L-(+)-lactic acid201-196-279-33-4
p-(1,1-dimethylpropyl)phenol201-280-980-46-6
Pin-2(3)-ene201-291-980-56-8
Sennoside A201-339-981-27-6
Warfarin201-377-681-81-2
Coumachlor201-378-181-82-3
Diphacinone201-434-582-66-6
Ethyl quinine carbonate201-500-383-75-0
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one/Rotenone201-501-983-79-4
Anthraquinone201-549-084-65-1
Dibutyl phthalate201-557-484-74-2
Salicylanilide201-727-887-17-2
(+)-tartaric acid201-766-087-69-4
Pentachlorophenol201-778-687-86-5
Symclosene201-782-887-90-1
Chloroxylenol201-793-888-04-0
2,4,6-trichlorophenol201-795-988-06-2
Menthol201-939-089-78-1
Isopulegol201-940-689-79-2
Thymol201-944-889-83-8
Guaiacol/2-methoxyphenol201-964-790-05-1
Biphenyl-2-ol201-993-590-43-7
Naphthalene202-049-591-20-3
Propyl 4-hydroxybenzoate202-307-794-13-3
Butyl 4-hydroxybenzoate202-318-794-26-8
Dibenzoyl peroxide202-327-694-36-0
2-ethylhexane-1,3-diol202-377-994-96-2
Benzotriazole202-394-195-14-7
3-chloropropane-1,2-diol202-492-496-24-2
Dichlorophen202-567-197-23-4
Eugenol202-589-197-53-0
Allantoin202-592-897-59-6
Methyl 4-hydroxybenzoate202-785-799-76-3
Benzyl alcohol202-859-9100-51-6
2,2′-[(1,1,3-trimethylpropane-1,3-diyl)bis(oxy)]bis[4,4,6-trimethyl-1,3,2-dioxaborinane]202-899-7100-89-0
Methenamine/Hexamethylenetetramine202-905-8100-97-0
Triclocarban202-924-1101-20-2
Chlorpropham202-925-7101-21-3
1,1′,1″,1‴!-ethylenedinitrilotetrapropan-2-ol203-041-4102-60-3
2,2′,2″-nitrilotriethanol203-049-8102-71-6
Chlorphenesin203-192-6104-29-0
Anethole203-205-5104-46-1
Cinnamaldehyde/3-phenyl-propen-2-al203-213-9104-55-2
2-ethylhexan-1-ol/Isooctanol203-234-3104-76-7
Citronellol203-375-0106-22-9
Citronellal203-376-6106-23-0
Geraniol203-377-1106-24-1
1,4-dichlorobenzene203-400-5106-46-7
Ethylendiamine203-468-6107-15-3
Chloro-acetaldehyde203-472-8107-20-0
Ethane-1,2-diol203-473-3107-21-1
Glyoxal203-474-9107-22-2
Methyl formate203-481-7107-31-3
Butane-1,3-diol203-529-7107-88-0
Vinyl acetate203-545-4108-05-4
Acetic anhydride203-564-8108-24-7
m-Cresol203-577-9108-39-4
Resorcinol203-585-2108-46-3
Cyanuric acid203-618-0108-80-5
Phenol203-632-7108-95-2
Ethyl formate203-721-0109-94-4
Succinic acid203-740-4110-15-6
Hexa-2,4-dienoic acid/Sorbic acid203-768-7110-44-1
Pyridine203-809-9110-86-1
Morpholine203-815-1110-91-8
Glutaral203-856-5111-30-8
2-Butoxyethanol203-905-0111-76-2
Cetrimonium chloride/Hexadecyl-trimethylammoniumchloride203-928-6112-02-7
Nonanoic acid203-931-2112-05-0
Undecan-2-one/Methyl-nonyl-ketone203-937-5112-12-9
2,2′-(ethylenedioxy)diethanol/Triethylene-glycol203-953-2112-27-6
Undec-10-enoic acid203-965-8112-38-9
Oleic acid204-007-1112-80-1
(Z)-docos-13-enoic acid204-011-3112-86-7
N-(2-ethylhexyl)-8,9,10-trinorborn-5-ene-2,3-dicarboximide204-029-1113-48-4
Propoxur204-043-8114-26-1
Endosulfan204-079-4115-29-7
1,7,7-trimethylbicyclo[2.2.1]hept-2-yl thiocyanatoacetate204-081-5115-31-1
Dicofol204-082-0115-32-2
Linalyl acetate204-116-4115-95-7
3,3′,4′,5,7-pentahydroxyflavone204-187-1117-39-5
1,3-dichloro-5,5-dimethylhydantoin204-258-7118-52-5
Methyl salicylate204-317-7119-36-8
Clorophene204-385-8120-32-1
Ethyl 4-hydroxybenzoate204-399-4120-47-8
Benzyl benzoate204-402-9120-51-4
Piperonal204-409-7120-57-0
Indole204-420-7120-72-9
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl-2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-cyclopropanecarboxylate/Cinerin II204-454-2121-20-0
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)],3.beta.]]-chrysanthemate/Pyrethrin I204-455-8121-21-1
2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1.alpha.[S*(Z)](3.beta.)-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate/Pyrethrin II204-462-6121-29-9
Benzethonium chloride204-479-9121-54-0
5-nitrothiazol-2-ylamine204-490-9121-66-4
Malathion204-497-7121-75-5
Fenitrothion204-524-2122-14-5
Cetalkonium chloride204-526-3122-18-9
Benzyldimethyl(octadecyl)ammonium chloride204-527-9122-19-0
Simazine204-535-2122-34-9
Propham204-542-0122-42-9
4-Phenylbutanone204-555-1122-57-6
2-Phenoxyethanol204-589-7122-99-6
Cetylpyridinium chloride204-593-9123-03-5
Cetylpyridinium chloride monohydrate204-593-96004-24-6
2-Ethylhexanal204-596-5123-05-7
Pyridazine-3,6-diol/Maleic hydrazide204-619-9123-33-1
Adipic acid204-673-3124-04-9
Octanoic acid204-677-5124-07-2
Dodecylamine/Laurylamine204-690-6124-22-1
Carbon dioxide204-696-9124-38-9
Sodium dimethylarsinate204-708-2124-65-2
Exo-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol204-712-4124-76-5
Nitromethylidynetrimethanol204-769-5126-11-4
Sodium acetate204-823-8127-09-3
Sodium N-chlorobenzenesulphonamide204-847-9127-52-6
Tosylchloramide sodium204-854-7127-65-1
Bis(2,3,3,3-tetrachloropropyl) ether204-870-4127-90-2
Potassium dimethyldithiocarbamate204-875-1128-03-0
Sodium dimethyldithiocarbamate204-876-7128-04-1
N-bromosuccinimide204-877-2128-08-5
N-chlorosuccinimide204-878-8128-09-6
2,6-di-tert-butyl-p-cresol204-881-4128-37-0
Warfarin sodium204-929-4129-06-6
Dimethyl phthalate205-011-6131-11-3
Sodium pentachlorophenolate205-025-2131-52-2
Sodium 2-biphenylate205-055-6132-27-4
Sodium 2-biphenylate tetrahydrate205-055-66152-33-6
Captan205-087-0133-06-2
N-(trichloromethylthio)phthalimide/Folpet205-088-6133-07-3
2,4-Dichloro-3,5-xylenol205-109-9133-53-9
Methyl anthranilate205-132-4134-20-3
Bis(8-hydroxyquinolinium) sulphate205-137-1134-31-6
N,N-diethyl-m-toluamide205-149-7134-62-3
Dipropyl pyridine-2,5-dicarboxylate205-245-9136-45-8
Zinc bis(2-ethylhexanoate)205-251-1136-53-8
6-methylbenzotriazole205-265-8136-85-6
Thiram205-286-2137-26-8
Ziram205-288-3137-30-4
Sodium propionate205-290-4137-40-6
Potassium methyldithiocarbamate205-292-5137-41-7
Metam-sodium205-293-0137-42-8
Dipentene205-341-0138-86-3
Disodium cyanodithiocarbamate205-346-8138-93-2
Benzododecinium chloride205-351-5139-07-1
Miristalkonium chloride205-352-0139-08-2
Nitrilo triacetic acid205-355-7139-13-9
p-tolyl acetate205-413-1140-39-6
1,3-bis(hydroxymethyl)urea205-444-0140-95-4
Sodium formate205-488-0141-53-7
2,3-dihydroxypropyl laurate205-526-6142-18-7
Nabam205-547-0142-59-6
Hexanoic acid205-550-7142-62-1
Lauric acid205-582-1143-07-7
Potassium oleate205-590-5143-18-0
Sodium hydrogencarbonate205-633-8144-55-8
Oxalic acid205-634-3144-62-7
Quinolin-8-ol205-711-1148-24-3
Thiabendazole205-725-8148-79-8
Benzothiazole-2-thiol205-736-8149-30-4
Monuron205-766-1150-68-5
Rutoside205-814-1153-18-4
Glyoxylic acid206-058-5298-12-4
Fenchlorphos206-082-6299-84-3
Naled206-098-3300-76-5
5-chlorosalicylic acid206-283-9321-14-2
Diuron206-354-4330-54-1
Potassium thiocyanate206-370-1333-20-0
Diazinon206-373-8333-41-5
Decanoic acid206-376-4334-48-5
Cyanamide206-992-3420-04-2
Metronidazole207-136-1443-48-1
Cineole207-431-5470-82-6
7,8-dihydroxycoumarin207-632-8486-35-1
Sodium carbonate207-838-8497-19-8
2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one207-880-7499-44-5
Carvacrol207-889-6499-75-2
6.beta.-acetoxy-3beta-(beta.-D-glucopyranosyloxy)-8,14-dihydroxybufa-4,20,22-trienolide/Scilliroside208-077-4507-60-8
Barium carbonate208-167-3513-77-9
3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione208-293-9520-45-6
Osalmid208-385-9526-18-1
2,6-Dimethoxy-p-benzoquinone208-484-7530-55-2
Acridine-3,6-diamine dihydrochloride208-515-4531-73-7
Sodium benzoate208-534-8532-32-1
Dazomet208-576-7533-74-4
Trisodium hydrogendicarbonate/Sodium sesquicarbonate208-580-9533-96-0
Silver carbonate208-590-3534-16-7
Crimidine208-622-6535-89-7
Calcium diformate208-863-7544-17-2
Myristic acid208-875-2544-63-8
1-isopropyl-4-methylbicyclo[3.1.0]hexan-3-one208-912-2546-80-5
1,3,4,6,8,13-hexahydroxy-10,11-dimethylphenanthro[1,10,9,8-opqra]perylene-7,14-dione/Hypericum perforatum208-941-0548-04-9
[4-[4,4′-bis(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride208-953-6548-62-9
Zinc dibenzoate209-047-3553-72-0
Methyl isothiocyanate209-132-5556-61-6
4,4′-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride209-321-2569-61-9
[4-[alpha-[4-(dimethylamino)phenyl]benzylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride/Malachite green chloride209-322-8569-64-2
Potassium benzoate209-481-3582-25-2
(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl-(1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (all isomers; ratio: 1:1:1:1:1:1:1:1)/Allethrin209-542-4584-79-2
Sodium 3-(p-anilinophenylazo)benzenesulphonate/Metanil yellow209-608-2587-98-4
DL-lactic acid209-954-4598-82-3
BHC or HCH/Hexachlorocyclohexane210-168-9608-73-1
DL-malic acid210-514-9617-48-1
N-(hydroxymethyl)acetamide210-897-2625-51-4
Succinaldehyde211-333-8638-37-9
2-fluoroacetamide211-363-1640-19-7
Phthalaldehyde211-402-2643-79-8
2-hydroxyethanesulphonic acid, compound with 4,4′-[hexane-1,6-diylbis(oxy)]bis[benzenecarboxamidine] (2:1)211-533-5659-40-5
Tetrahydro-2,5-dimethoxyfuran211-797-1696-59-3
N-[(dichlorofluoromethyl)thio]phthalimide211-952-3719-96-0
Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/Tolylfluanid211-986-9731-27-1
Levonorgestrel212-349-8797-63-7
Hydroxyl-2-pyridone212-506-0822-89-9
2,6-dimethyl-1,3-dioxan-4-yl acetate212-579-9828-00-2
Terbutryn212-950-5886-50-0
Proflavine hydrochloride213-459-9952-23-8
N′1-quinoxalin-2-ylsulphanilamide, sodium salt213-526-2967-80-6
Norbormide213-589-6991-42-4
(hydroxymethyl)urea213-674-81000-82-4
Dichlofluanid214-118-71085-98-9
Copper thiocyanate214-183-11111-67-7
Dodecyltrimethylammonium bromide214-290-31119-94-4
Tetradonium bromide214-291-91119-97-7
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-Tetramethrin214-619-01166-46-7
4,5-dichloro-3H-1,2-dithiol-3-one214-754-51192-52-5
Xylenol215-089-31300-71-6
Bentonite215-108-51302-78-9
Diarsenic pentaoxide215-116-91303-28-2
Diboron trioxide215-125-81303-86-2
Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked lime215-137-31305-62-0
Calcium oxide/lime/burnt lime/quicklime215-138-91305-78-8
Potassium hydroxide215-181-31310-58-3
Sodium hydroxide215-185-51310-73-2
Silicic acid, potassium salt/Potassium silicate215-199-11312-76-1
Zinc oxide215-222-51314-13-2
Trizinc diphosphide215-244-51314-84-7
Zinc sulphide215-251-31314-98-3
Trimanganese tetraoxide215-266-51317-35-7
Copper oxide215-269-11317-38-0
Dicopper oxide215-270-71317-39-1
Cresol215-293-21319-77-3
Aluminum chloride, basic215-477-21327-41-9
Disodium tetraborate, anhydrous215-540-41330-43-4
Disodium tetraborate decahydrate215-540-41303-96-4
Dicopper chloride trihydroxide215-572-91332-65-6
Chromium trioxide215-607-81333-82-0
Sodium hydrogendifluoride215-608-31333-83-1
Naphthenic acids, copper salts215-657-01338-02-9
2-Butanone, peroxide215-661-21338-23-4
Naphthenic acids215-662-81338-24-5
Ammonium hydrogendifluoride215-676-41341-49-7
Silicic acid, sodium salt215-687-41344-09-8
Copper(II) chloride215-704-51344-67-8
N,N″-bis(2-ethylhexyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine dihydrochloride216-994-61715-30-6
Monolinuron217-129-51746-81-2
2,4-dichlorobenzyl alcohol217-210-51777-82-8
Ethacridine lactate217-408-11837-57-6
4,4′-(2-ethyl-2-nitropropane-1,3-diyl)bismorpholine217-450-01854-23-5
Chlorothalonil217-588-11897-45-6
Dodecylammonium acetate217-956-12016-56-0
Fluometuron218-500-42164-17-2
Allyl propyl disulphide218-550-72179-59-1
4-(2-nitrobutyl)morpholine218-748-32224-44-4
N-(3-aminopropyl)-N-dodecylpropane-1,3-diamine219-145-82372-82-9
Didecyldimethylammonium bromide219-234-12390-68-3
Tolnaftate219-266-62398-96-1
Bis[[4-[4-(dimethylamino)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium] oxalate, dioxalate219-441-72437-29-8
Dodine219-459-52439-10-3
2-bromo-1-(4-hydroxyphenyl)ethan-1-one219-655-02491-38-5
2,2′-dithiobis[N-methylbenzamide]219-768-52527-58-4
2,2′-[methylenebis(oxy)]bisethanol219-891-42565-36-8
Phenthoate219-997-02597-03-7
1,2-benzisothiazol-3(2H)-one220-120-92634-33-5
2,2′-[(1-methylpropane-1,3-diyl)bis(oxy)]bis[4-methyl-1,3,2-dioxaborinane]220-198-42665-13-6
2-methyl-2H-isothiazol-3-one220-239-62682-20-4
Sulphuryl difluoride220-281-52699-79-8
2-Amino-3-chloro-1,4-naphthoquinone220-529-22797-51-5
2-chloro-N-(hydroxymethyl)acetamide220-598-92832-19-1
Troclosene sodium220-767-72893-78-9
Sodium dichloroisocyanurate dihydrate220-767-751580-86-0
Chlorpyrifos220-864-42921-88-2
Mecetronium ethyl sulphate221-106-53006-10-8
Dodecylethyldimethylammonium ethyl sulphate221-108-63006-13-1
Bis(trichloromethyl) sulphone221-310-43064-70-8
Sodium 2-(2-dodecyloxyethoxy)ethyl sulphate221-416-03088-31-1
4-isopropyl-m-cresol221-761-73228-02-2
Copper dinitrate221-838-53251-23-8
Triclosan222-182-23380-34-5
Temephos222-191-13383-96-8
Thuj-4(10)-ene222-212-43387-41-5
Oct-1-ene-3-ol222-226-03391-86-4
Sodium 5-chloro-2-[4-chloro-2-[[[(3,4-dichlorophenyl)amino]carbonyl]amino]phenoxy]benzenesulphonate222-654-83567-25-7
(ethylenedioxy)dimethanol222-720-63586-55-8
Chlorophacinone223-003-03691-35-8
Dipyrithione223-024-53696-28-4
Chlorhexidine dihydrochloride223-026-63697-42-5
Denatonium benzoate223-095-23734-33-6
Sodium 2,4,6-trichlorophenolate223-246-23784-03-0
Pyridine-2-thiol 1-oxide, sodium salt223-296-53811-73-2
Hexahydro-1,3,5-tris(3-methoxypropyl)-1,3,5-triazine223-563-63960-05-2
4-oxo-4-[(tributylstannyl)oxy]but-2-enoic acid/Tributyltin maleate223-701-54027-18-3
Methenamine 3-chloroallylochloride223-805-04080-31-3
N-ethylheptadecafluorooctanesulphonamide223-980-34151-50-2
Isobutyl 4-hydroxybenzoate/Isobutyl parabene224-208-84247-02-3
Tributylstannyl salicylate/Tributyltin salicylate224-397-74342-30-7
Tributylstannyl benzoate/Tributyltin benzoate224-399-84342-36-3
Sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethanolate224-580-14418-26-2
Diethylammonium salicylate224-586-44419-92-5
Dimethyl dicarbonate224-859-84525-33-1
Farnesol225-004-14602-84-0
2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol225-208-04719-04-4
Octylphosphonic acid225-218-54724-48-5
Sodium 4-(methoxycarbonyl)phenolate225-714-15026-62-0
Sulphamidic acid226-218-85329-14-6
Citral226-394-65392-40-5
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione226-408-05395-50-6
1-benzyl-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane chloride226-445-25400-93-1
Dimethyldioctylammonium chloride226-901-05538-94-3
N-dodecylpropane-1,3-diamine226-902-65538-95-4
Chlorpyrifos-methyl227-011-55598-13-0
N,N′-methylenebismorpholine227-062-35625-90-1
Coumatetralyl227-424-05836-29-3
Terbuthylazine227-637-95915-41-3
(R)-p-mentha-1,8-diene227-813-55989-27-5
4-methoxybenzene-1,3-diamine sulphate228-290-66219-67-6
Methylene dithiocyanate228-652-36317-18-6
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione229-222-86440-58-0
Dodicin229-930-76843-97-6
Malic acid230-022-86915-15-7
(2-bromo-2-nitrovinyl)benzene230-515-87166-19-0
Didecyldimethylammonium chloride230-525-27173-51-5
(Z)-N-9-octadecenylpropane-1,3-diamine230-528-97173-62-8
Benzyldodecyldimethylammonium bromide230-698-47281-04-1
Prometryn230-711-37287-19-6
Silver231-131-37440-22-4
Boron231-151-27440-42-8
Copper231-159-67440-50-8
Zinc231-175-37440-66-6
Sulphur dioxide231-195-27446-09-5
Dithallium sulphate231-201-37446-18-6
Calcium dihexa-2,4-dienoate231-321-67492-55-9
Quinine monohydrochloride dihydrate231-437-76119-47-7
Iodine231-442-47553-56-2
Iodine in the form of iodophorMixture39392-86-4
Iodine complex in solution with non-ionic detergentsMixture
Polyvinylpyrrolidone iodinePolymer25655-41-8
Alkylaryl polyether alcohol-iodine complexPolymer
Iodine complex with ethylene-propylene block co-Polymer (pluronic)Polymer
Iodine complex with poly alkylenglycolPolymer
Iodinated Resin/Polyiodide Anion ResinPolymer
Trisodium orthophosphate (TSP)231-509-87601-54-9
Silicon dioxide — amorphous231-545-47631-86-9
Sodium hydrogensulphite231-548-07631-90-5
Sodium nitrite231-555-97632-00-0
Sodium peroxometaborate/Sodium perborate hydrate231-556-47632-04-4
Hydrogen chloride/Hydrochloric acid231-595-77647-01-0
Sodium chloride231-598-37647-14-5
Sodium bromide231-599-97647-15-6
Orthophosphoric acid231-633-27664-38-2
Hydrogen fluoride231-634-87664-39-3
Ammonia, anhydrous231-635-37664-41-7
Sulphuric acid231-639-57664-93-9
Potassium iodide231-659-47681-11-0
Sodium hydrogensulphate231-665-77681-38-1
Sodium fluoride231-667-87681-49-4
Sodium hypochlorite231-668-37681-52-9
Disodium disulphite231-673-07681-57-4
Tetramethrin231-711-67696-12-0
Sulphur231-722-67704-34-9
Iron sulphate231-753-57720-78-7
Iron vitriol/Ferrous sulphate heptahydrate/Iron sulphate heptahydrate231-753-57782-63-0
Potassium permanganate231-760-37722-64-7
Hydrogen peroxide231-765-07722-84-1
Bromine231-778-17726-95-6
Dipotassium peroxodisulphate231-781-87727-21-1
Nitrogen231-783-97727-37-9
Zinc sulphate heptahydrate231-793-37446-20-0
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole231-810-47747-35-5
Sodium sulphite231-821-47757-83-7
Sodium chlorite231-836-67758-19-2
Copper chloride231-842-97758-89-6
Copper sulphate231-847-67758-98-7
Copper sulphate pentahydrate231-847-67758-99-8
Silver nitrate231-853-97761-88-8
Sodium thiosulphate pentahydrate231-867-510102-17-7
Sodium chlorate231-887-47775-09-9
Disodium peroxodisulphate/Sodium persulphate231-892-17775-27-1
Potassium dichromate231-906-67778-50-9
Calcium hypochlorite231-908-77778-54-3
Hexahydro-1,3,5-triethyl-1,3,5-triazine231-924-47779-27-3
Chlorine231-959-57782-50-5
Ammonium sulphate231-984-17783-20-2
Silver chloride232-033-37783-90-6
Aluminium ammonium bis(sulphate)232-055-37784-25-0
Manganese sulphate232-089-97785-87-7
Manganese sulphate tetrahydrate232-089-910101-68-5
Iodine monochloride232-236-77790-99-0
Terpineol232-268-18000-41-7
Soybean oil232-274-48001-22-7
Linseed oil232-278-68001-26-1
Corn oil232-281-28001-30-7
Coconut oil232-282-88001-31-8
Creosote232-287-58001-58-9
Castor oil232-293-88001-79-4
Bone oil/Animal oil232-294-38001-85-2
Rape oil232-299-08002-13-9
Pyrethrins and Pyrethroids232-319-88003-34-7
Terpinol—8006-39-1
Turpentine oil232-350-78006-64-2
Garlic ext.232-371-18008-99-9
Tar, pine/Pine wood tar232-374-88011-48-1
Beeswax232-383-78012-89-3
Paraffin oils232-384-28012-95-1
Oils, avocado232-428-08024-32-6
Orange, sweet, ext.232-433-88028-48-6
White mineral oil (petroleum)232-455-88042-47-5
Saponins232-462-68047-15-2
Tall-oil rosin232-484-68052-10-6
Asphalt/Bitumen232-490-98052-42-4
Copals232-527-99000-14-0
Lignin232-682-29005-53-2
Aluminium sulphate233-135-010043-01-3
Boric acid233-139-210043-35-3
Aluminium potassium bis(sulphate)/Alum233-141-310043-67-1
Chlorine dioxide233-162-810049-04-4
Potassium sulphite233-321-110117-38-1
Sodium hydrogen 2,2′methylenebis[4-chlorophenolate]233-457-110187-52-7
2,2-dibromo-2-cyanoacetamide233-539-710222-01-2
Disilver(1+) sulphate233-653-710294-26-5
Sodium metaphosphate233-782-910361-03-2
Oxine-copper233-841-910380-28-6
Resmethrin233-940-710453-86-8
N,N′-ethylenebis[N-acetylacetamide]234-123-810543-57-4
Sodium dichromate234-190-310588-01-9
Carbendazim234-232-010605-21-7
Tridecasodium hypochloritetetrakis(phosphate)234-307-811084-85-8
Natural boric acid234-343-411113-50-1
Sodium perborate tetrahydrate234-390-010486-00-7
Perboric acid, sodium salt234-390-011138-47-9
Naphthenic acids, zinc salts234-409-212001-85-3
Disodium octaborate234-541-012008-41-2
Disodium octaborate tetrahydrate234-541-012280-03-4
[2H4]ammonium chloride234-607-912015-14-4
Dialuminium chloride pentahydroxide234-933-112042-91-0
Trimagnesium diphosphide235-023-712057-74-8
Sodium toluenesulphonate235-088-112068-03-0
Copper(II) carbonate-copper(II) hydroxide (1:1)235-113-612069-69-1
Zineb235-180-112122-67-7
Ammonium bromide235-183-812124-97-9
Tetraboron disodium heptaoxide, hydrate235-541-312267-73-1
Maneb235-654-812427-38-2
Hexaboron dizinc undecaoxide/Zinc borate235-804-212767-90-7
N-(hydroxymethyl)formamide235-938-113052-19-2
2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine236-035-513108-52-6
Nifurpirinol236-503-913411-16-0
Pyrithione zinc236-671-313463-41-7
Titanium dioxide236-675-513463-67-7
Dodecylguanidine monohydrochloride237-030-013590-97-1
Barium diboron tetraoxide237-222-413701-59-2
Potassium 2-biphenylate237-243-913707-65-8
Ammonium tetrafluoroborate237-531-413826-83-0
Lithium hypochlorite237-558-113840-33-0
Orthoboric acid, sodium salt237-560-213840-56-7
Bromine chloride237-601-413863-41-7
Zinc bis(diethyldithiocarbamate)238-270-914324-55-1
(benzyloxy)methanol238-588-814548-60-8
2,2′-oxybis[4,4,6-trimethyl-1,3,2-dioxaborinane]238-749-214697-50-8
Phoxim238-887-314816-18-3
Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper238-984-014915-37-8
Bis(8-hydroxyquinolyl) sulphate, monopotassium salt239-133-615077-57-3
Dibromopropionamide239-153-515102-42-8
Sodium perborate monohydrate239-172-910332-33-9
2,2′-methylenebis(6-bromo-4-chlorophenol)239-446-815435-29-7
Chlorotoluron239-592-215545-48-9
Disodium carbonate, compound with hydrogen peroxide (2:3)239-707-615630-89-4
Sodium p-chloro-m-cresolate239-825-815733-22-9
Chloralose240-016-715879-93-3
1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione240-230-016079-88-2
(R)-2-(4-chloro-2-methylphenoxy)propionic acid240-539-016484-77-8
Dipotassium disulphite240-795-316731-55-8
Methomyl240-815-016752-77-5
Disodium hexafluorosilicate240-934-816893-85-9
Hexafluorosilicic acid241-034-816961-83-4
Benomyl241-775-717804-35-2
D-gluconic acid, compound with N,N″-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1)242-354-018472-51-0
O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate242-624-818854-01-8
Benzoxonium chloride243-008-119379-90-9
Methyl hydroxymethoxyacetate243-271-219757-97-2
p-[(diiodomethyl)sulphonyl]toluene243-468-320018-09-1
Copper dihydroxide243-815-920427-59-2
Disilver oxide243-957-120667-12-3
2-butene-1,4-diyl bis(bromoacetate)243-962-920679-58-7
Aluminium phosphide244-088-020859-73-8
(benzothiazol-2-ylthio)methyl thiocyanate244-445-021564-17-0
Tetrachlorvinphos244-865-422248-79-9
Bendiocarb245-216-822781-23-3
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Prallethrin245-387-923031-36-9
Potassium (E,E)-hexa-2,4-dienoate246-376-124634-61-5
2-tert-Butyl-4-methoxyphenol246-563-825013-16-5
Bis(hydroxymethyl)urea246-679-925155-29-7
.alpha.,.alpha.′,.alpha.″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanol246-764-025254-50-6
2,2′-(octadec-9-enylimino)bisethanol246-807-325307-17-9
3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Cinerin I246-948-025402-06-6
3-phenoxybenzyl 2-dimethyl-3-(methylpropenyl)cyclopropanecarboxylate/Phenothrin247-404-526002-80-2
5-chloro-2-methyl-2H-isothiazol-3-one247-500-726172-55-4
2-octyl-2H-isothiazol-3-one247-761-726530-20-1
Dodecylbenzenesulphonic acid248-289-427176-87-0
Lauric acid, monoester with glycerol248-337-427215-38-9
Zinc neodecanoate248-370-427253-29-8
Dodecyl(ethylbenzyl)dimethylammonium chloride248-486-527479-28-3
Cis-tricos-9-ene248-505-727519-02-4
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride248-595-827668-52-6
N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine248-872-328159-98-0
(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (only 1R trans, 1S isomer)/S-Bioallethrin249-013-528434-00-6
Bioresmethrin249-014-028434-01-7
3-[3-(4′-bromo[1,1′-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-benzopyrone/Bromadiolone249-205-928772-56-7
Pirimiphos-methyl249-528-529232-93-7
Lithium heptadecafluorooctanesulphonate249-644-629457-72-5
5-bromo-5-nitro-1,3-dioxane250-001-730007-47-7
Trans-isopropyl-3-[[(ethylamino)methoxyphosphinothioyl]oxy]crotonate250-517-231218-83-4
(Z,E)-tetradeca-9,12-dienyl acetate250-753-630507-70-1
Decyldimethyloctylammonium chloride251-035-532426-11-2
Bromochloro-5,5-dimethylimidazolidine-2,4-dione251-171-532718-18-6
Amitraz251-375-433089-61-1
3-(4-isopropylphenyl)-1,1-dimethylurea/Isoproturon251-835-434123-59-6
2-(hydroxymethylamino)ethanol251-974-034375-28-5
N-[3-(dodecylamino)propyl]glycine251-993-434395-72-7
2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3(2H,9bH)-dione, monosodium salt252-204-634769-44-3
Sodium 4-ethoxycarbonylphenoxide252-487-635285-68-8
Sodium 4-propoxycarbonylphenoxide252-488-135285-69-9
N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide252-529-335367-38-5
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole/Imazalil252-615-035554-44-0
(±)-1-(.beta.-allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalilPlant protection product73790-28-0
S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate/Azamethiphos252-626-035575-96-3
2-bromo-2-(bromomethyl)pentanedinitrile252-681-035691-65-7
Benzyldimethyloleylammonium chloride253-363-437139-99-4
Calcium magnesium oxide/dolomitic lime253-425-037247-91-9
Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated dolomitic lime254-454-139445-23-3
2-phosphonobutane-1,2,4-tricarboxylic acid253-733-537971-36-1
4-methoxy-m-phenylenediammonium sulphate254-323-939156-41-7
N,N″-methylenebis[N′-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea]254-372-639236-46-9
Dinocap254-408-039300-45-3
alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate254-484-539515-40-7
Isopropyl (2E,4E)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate/Methoprene254-993-240596-69-8
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloride255-451-841591-87-1
Mixture of cis- and trans-p-menthane-3,8 diol/Citriodiol255-953-742822-86-6
4,4-dimethyloxazolidine257-048-251200-87-4
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-cis)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate257-144-451348-90-4
Cyano (3-phenoxybenzyl)-2-(4-chlorophenyl)-3-methylbutyrate/Fenvalerate257-326-351630-58-1
ethyl N-acetyl-N-butyl-.beta.-alaninate257-835-052304-36-6
.alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cypermethrin257-842-952315-07-8
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Permethrin258-067-952645-53-1
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate/Deltamethrin258-256-652918-63-5
bis(2-ethylhexanoato-O)-.mu.-oxodizinc259-049-354262-78-1
1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/Empenthrin259-154-454406-48-3
3-iodo-2-propynyl butylcarbamate259-627-555406-53-6
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1)259-709-055566-30-8
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/Difenacoum259-978-456073-07-5
4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/Brodifacoum259-980-556073-10-0
[2-(2-butoxyethoxy)ethoxy]methanol260-097-256289-76-0
2-ethoxyethyl bromoacetate260-240-956521-73-4
N-octyl-N′-[2-(octylamino)ethyl]ethylenediamine260-725-557413-95-3
1,2-benzisothiazol-3(2H)-one, sodium salt261-184-858249-25-5
Azaconazole262-102-360207-31-0
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/Propiconazole262-104-460207-90-1
N,N-bis(2-hydroxyethyl)undec-10-enamide262-114-960239-68-1
2-chloro-3-(phenylsulphonyl)acrylonitrile262-395-860736-58-5
Tetradecyldimethylbenzylammonium fluoride—61134-95-0
[1,1′-Biphenyl]-2-ol, chlorinated262-974-561788-42-9
Amines, coco alkyl262-977-161788-46-3
Quaternary ammonium compounds, (hydrogenated tallow alkyl)trimethyl, chlorides263-005-961788-78-1
Quaternary ammonium compounds, coco alkyltrimethyl, chlorides263-038-961789-18-2
Quaternary ammonium compounds, benzylcoco alkylbis(hydroxyethyl), chlorides263-078-761789-68-2
Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides263-080-861789-71-7
Quaternary ammonium compounds, dicocoalkyl dimethyl, chlorides263-087-661789-77-3
Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides263-090-261789-80-8
Quaternary ammonium compounds, trimethylsoya alkyl, chlorides263-134-061790-41-8
Ethanol, 2,2′-iminobis-, N-coco alkyl derivs.263-163-961791-31-9
1H-Imidazole-1-ethanol, 4,5-dihydro-, 2-nortall-oil alkyl derivs.263-171-261791-39-7
Imidazolium compounds, 1-benzyl-4,5-dihydro-1-(hydroxyethyl)-2-norcoco alkyl, chlorides263-185-961791-52-4
Amines, N-tallow alkyldipropylenetri-263-191-161791-57-9
Amines, N-coco alkyltrimethylenedi-263-195-361791-63-7
Amines, N-coco alkyltrimethylenedi-, acetates263-196-961791-64-8
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides264-151-663449-41-2
4,5-dichloro-2-octyl-2H-isothiazol-3-one264-843-864359-81-5
2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamide264-980-364628-44-0
Distillates (petroleum), solvent-refined light naphthenic265-098-164741-97-5
Distillates (petroleum), hydrotreated light265-149-864742-47-8
N-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-6-hydroxy-1,3-dimethyl-2,4-dioxopyrimidine-5-carboxamide265-732-765400-98-8
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate265-898-065731-84-2
Tar acids, coal, crude266-019-365996-85-2
Glass powder266-046-065997-17-3
3,3′-methylenebis[5-methyloxazolidine]/Oxazolidin266-235-866204-44-2
N-cyclopropyl-1,3,5-triazine-2,4,6-triamine266-257-866215-27-8
Betaines, C12-C14-alkyl dimethyl266-368-166455-29-6
.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(1,2,2,2-tetrabromoethyl)cyclopropanecarboxylate/Tralomethrin266-493-166841-25-6
2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-ylmethyl)acetamide266-583-067129-08-2
Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine266-719-967564-91-4
N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide266-994-567747-09-5
Fatty acids, C16-18 and C18-unsatd., Me esters267-015-467762-38-3
.alpha-cyano-3-phenoxybenzyl 3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethyl cyclopropanecarboxylate/Cyhalothrin268-450-268085-85-8
Dodecylethyldimethylammonium bromide/Laudacit269-249-268207-00-1
Shale oils269-646-068308-34-9
.alpha.-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/Cyfluthrin269-855-768359-37-5
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chlorides269-919-468391-01-5
Quaternary ammonium compounds, di-C6-12-alkyldimethyl, chlorides269-925-768391-06-0
Benzenesulfonic acid, C10-13-alkyl derivs., sodium salts270-115-068411-30-3
Quaternary ammonium compounds, benzyl-C8-16-alkyldimethyl, chlorides270-324-768424-84-0
Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides270-325-268424-85-1
Betaines, coco alkyldimethyl270-329-468424-94-2
Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chlorides270-331-568424-95-3
Fatty acids, coco, reaction products with diethanolamine270-430-368440-04-0
1-Propanaminium, 3-amino-N,N,N-trimethyl-, N-C12-18 acyl derivs., Me sulfates271-063-168514-93-2
Amides, coco, N,N-bis(2-hydroxyethyl)271-657-068603-42-9
Quaternary ammonium compounds, (oxydi-2,1-ethanediyl)bis[coco alkyldimethyl, dichlorides271-761-668607-28-3
9-Octadecenoic acid (Z)-, sulfonated, potassium salts271-843-168609-93-8
Urea, reaction products with formaldehyde271-898-168611-64-3
Imidazolium compounds, 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-norcoco alkyl, hydroxides, sodium salts272-043-568650-39-5
bis(tetraamminecopper) carbonatedihydroxide272-415-768833-88-5
1-hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)pyridin-2(1H)-one, compound with 2-aminoethanol (1:1)272-574-268890-66-4
Amines, N-tallowalkyl trimethylenedi-, diacetates272-786-568911-78-4
Quassia, ext.272-809-968915-32-2
Fatty acids, C8-10273-086-268937-75-7
Sulfuric acid, mono-C12-18-alkyl esters, sodium salts273-257-168955-19-1
Quaternary ammonium compounds, C12-18-alkyl[(ethylphenyl)methyl]dimethyl, chlorides273-318-268956-79-6
Didecylmethyl[3-(trimethoxysilyl)propyl]ammonium chloride273-403-468959-20-6
Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides273-544-168989-00-4
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1)273-545-768989-01-5
Sodium N-(hydroxymethyl)glycinate274-357-870161-44-3
Amines, C10-16-alkyldimethyl, N-oxides274-687-270592-80-2
Pentapotassium bis(peroxymonosulphate) bis(sulphate)274-778-770693-62-8
N,N′-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichloride274-861-870775-75-6
1,3-didecyl-2-methyl-1H-imidazolium chloride274-948-070862-65-6
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/Fenoxycarb276-696-772490-01-8
Quaternary ammonium compounds, di-C8-18-alkyldimethyl, chlorides277-453-873398-64-8
1-[(hydroxymethyl)amino]propan-2-ol278-534-076733-35-2
1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/Diazolidinylurea278-928-278491-02-8
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-)279-013-078948-87-5
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydrate279-013-0114915-85-4
Tributyltetradecylphosphonium chloride279-808-281741-28-8
(2-Butoxyethoxy)methanol281-648-384000-92-0
Zinc, isodecanoate isononanoate complexes, basic282-786-784418-73-5
Juniper, Juniperus communis, ext.283-268-384603-69-0
Laurus nobilis, ext.283-272-584603-73-6
Rosemary, ext.283-291-984604-14-8
Eucalyptus globulus, ext.283-406-284625-32-1
Cinnamomum zeylanicum, ext.283-479-084649-98-9
Margosa ext.283-644-784696-25-3
Lavender, Lavandula angustifolia angustifolia, ext.283-994-084776-65-8
Thyme, Thymus serpyllum, ext.284-023-384776-98-7
Formaldehyde, reaction products with diethylene glycol284-062-684777-35-5
Formamide, reaction products with formaldehyde284-064-784777-37-7
Glycine, N-(3-aminopropyl)-, N′-C10-16-alkyl derivs.284-065-284777-38-8
Lemon, ext.284-515-884929-31-7
Thyme, Thymus vulgaris, ext.284-535-784929-51-1
Clove, ext.284-638-784961-50-2
Tar acids, polyalkylphenol fraction284-893-484989-05-9
Melaleuca alternifolia, ext./Australian Tea Tree Oil285-377-185085-48-9
2,4,8,10-tetra(tert-butyl)-6-hydroxy-12H-dibenzo[d,g][1,3,2]dioxaphosphocin 6-oxide, sodium salt286-344-485209-91-2
Formaldehyde, reaction products with propylene glycol286-695-385338-22-3
Stannane, tributyl-, mono(naphthenoyloxy) derivs.287-083-985409-17-2
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chlorides287-089-185409-22-9
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chlorides287-090-785409-23-0
[R-(Z)]-3-[(12-hydroxy-1-oxo-9-octadecenyl)amino]propyltrimethylammonium methyl sulphate287-462-985508-38-9
Benzenesulfonic acid, 4-C10-13-sec-alkyl derives.287-494-385536-14-7
Guanidine, N,N‴-1,3-propanediylbis-, N-coco alkyl derivs., diacetates288-198-785681-60-3
Sulfonic acids, C13-17-sec-alkane, sodium salts288-330-385711-69-9
.alpha.-cyano-4-fluoro-3-phenoxybenzyl [1.alpha.(S*),3.alpha.]-(±)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate289-244-986560-93-2
Chrysanthemum cinerariaefolium, ext.289-699-389997-63-7
Cymbopogon nardus, ext.289-753-689998-15-2
Lavender, Lavandula angustifolia, ext.289-995-290063-37-9
Litsea cubeba, ext.290-018-790063-59-5
Mentha arvensis, ext.290-058-590063-97-1
Pelargonium graveolens, ext.290-140-090082-51-2
Benzenesulfonic acid, mono-C10-14-alkyl derivs., compds. with Me 1H-benzimidazol-2-ylcarbamate290-651-990194-41-5
Copper, EDTA-complexes290-989-790294-99-8
Formaldehyde, reaction products with propanolamine291-325-990387-52-3
Urea, N,N′-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehyde292-348-790604-54-9
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides293-522-591080-29-4
Fir, Abies sibirica, ext.294-351-991697-89-1
Juniper, Juniperus mexicana, ext.294-461-791722-61-1
Lavender, Lavandula hybrida, ext./Lavandin oil294-470-691722-69-9
Amines, N-(3-aminopropyl)-N′-coco alkyltrimethylenedi-, monoacrylated294-702-691745-32-3
Cymbopogon winterianus, ext.294-954-791771-61-8
Lemongrass (Cymbopogon flexuosus)295-161-991844-92-7
White mineral oil (petroleum), light295-550-392062-35-6
N-[3-(dodecylamino)propyl]glycine hydrochloride298-216-593778-80-4
Bis(2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyl-1,3(2H,9bH)-dibenzofurandionato-O2,O3)copper304-146-994246-73-8
Citrus, ext.304-454-394266-47-4
Pine ext.304-455-994266-48-5
Trimethyl-3-[(1-oxo-10-undecenyl)amino]propylammonium methyl sulphate304-990-894313-91-4
Peppermint, American, ext.308-770-298306-02-6
Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner salts309-206-8100085-64-1
Corn cob, powdered310-127-6999999-99-4
Natural lemon juice (filtered)310-127-6999999-99-4
Hedera helix310-127-6999999-99-4
Onion Oil310-127-6999999-99-4
Thuja occidentalis310-127-6999999-99-4
Salvia officinalis310-127-6999999-99-4
Hyssopus officinalis310-127-6999999-99-4
Chrysanthemum vulgare310-127-6999999-99-4
Artemisia absinthium310-127-6999999-99-4
Achillea millefolium310-127-6999999-99-4
Origanum vulgare310-127-6999999-99-4
Majorana hortensis310-127-6999999-99-4
Origanum majorano310-127-6999999-99-4
Rosmarinus officinalis310-127-6999999-99-4
Satureja hortensis310-127-6999999-99-4
Uritica dioica310-127-6999999-99-4
Aesculus hippocastanum310-127-6999999-99-4
Symphytum officinale310-127-6999999-99-4
Equisetum arvense310-127-6999999-99-4
Sambucus nigra310-127-6999999-99-4
1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/Hexaflumuron401-400-186479-06-3
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione401-570-789415-87-2
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/Tebuconazole403-640-2107534-96-3
Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamine403-950-8164907-72-6
Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphate404-690-868132-19-4
(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate/Transfluthrin405-060-5118712-89-3
5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-(4-trifluoromethyl)cinnamylidenehydrazone/Hydramethylnon405-090-967485-29-4
3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/Etofenprox407-980-280844-07-1
6-(phthalimido)peroxyhexanoic acid410-850-8128275-31-0
Lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide411-690-1111337-53-2
Methyl neodecanamide414-460-9105726-67-8
Mixture of: alpha-cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate;alpha-cyano-3-phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate/Lambda cyhalothrin415-130-791465-08-6
1-(4-(2-cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea/Flufenoxuron417-680-3101463-69-8
2-butyl-benzo[d]isothiazol-3-one420-590-704299-07-4
Tetrachlorodecaoxide complex420-970-292047-76-2
Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/Flocoumafen421-960-090035-08-8
sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/Icaridine423-210-8119515-38-7
N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide423-990-1149118-66-1
Fipronil424-610-5120068-37-3
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/Imidacloprid428-040-8138261-41-3
Thiamethoxam428-650-4153719-23-4
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate; [2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/Imiprothrin428-790-672963-72-5
5-chloro-2-(4-chlorphenoxy)phenol429-209-03380-30-1
2-(1-methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/Pyriproxyfen429-800-195737-68-1
3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxide431-030-6163269-30-5
Reaction products of diisopropanolamine with formaldehyde(1:4)432-440-8220444-73-5
Chloromethyl n-octyl disulfide432-680-3180128-56-7
Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succinate with hydrogen peroxide/Perestane432-790-1
Bis(3-aminopropyl)octylamine433-340-786423-37-2
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine433-460-1210880-92-5
(E)-2-OctadecenalNot yet allocated51534-37-3
(E,Z)-2,13-OctadecadienalNot yet allocated99577-57-8
Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containingNot yet allocated398477-47-9
Silver sodium hydrogen zirconium phosphateNot yet allocated
Paraformaldehyde30525-89-4
Peroxyoctanoic acid33734-57-5
Bromomyristyl isoquinoline51808-87-8
9-Aminoacridine hydrochloride monohydrate52417-22-8
Chlorinated trisodium phosphate56802-99-4
Cyclohexylhydroxydiazene 1-oxide, potassium salt66603-10-9
(1S,2R,5S)-2-Isopropenyl-5-methylcyclohexanol104870-56-6
Silica, amorphous, crystalline-free112945-52-5
Denatonium Capsaicinate192327-95-0
Tris(N-cyclohexyldiazeniumdioxy)aluminium312600-88-7
Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copper312600-89-8
Reaction product of essential oils and ozone in-situ (Open Air Factor (OAF))
Silver zeolite A
Silver sodium borosilicate
5-Chloro-2-(4-chlorophenoxy)phenol
Benzyl-lauryl-dimethyl-myristylammonium chloride/Lauryl-myristyl dimethyl benzyl ammonium chloride
((1,2-Ethanediylbis(carbamodithioato))(2-))manganese mixture with ((1,2-ethandiylbis(carbamodithioate))(2-))zinc/MancozebPlant protection product8018-01-7
Chlorosulfamic acidPlant protection product17172-27-9
2-bromo-1-(2,4-dichlorophenyl)vinyl diethyl phosphate/bromfenvinfosPlant protection product33399-00-7
Ethyl (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoate/HydroprenePlant protection product41096-46-2
Silicium dioxide/KieselguhrPlant protection product61790-53-2
.alpha.,.alpha.,.alpha.-Trifluoro-N-methyl-4,6-dinitro-N-(2,4,6-tribromophenyl)-o-toluidine/BromethalinPlant protection product63333-35-7
S-Methoprene/Isopropyl (s-(E,E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoatePlant protection product65733-16-6
S-Hydroprene/Ethyl (S-(E,E))-3,7,11-trimethyldodeca-2,4-dienoatePlant protection product65733-18-8
Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyratePlant protection product66230-04-4
[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-CypermethrinPlant protection product67375-30-8
Abamectin (Mixture of Avermectin B1a; > 80 %, EINECS 265-610-3; and Avermectin B1b; < 20 % EINECS 265-611-9)265-610-371751-41-2
Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-methyl[1,1′-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/BiphenatePlant protection product82657-04-3
N-(2-((2,6-Dimethyl)phenyl)amino)-2-oxoethyl)-N,N-diethyl benzenemethanaminiumsaccharide/Denatonium SaccharidePlant protection product90823-38-4
.alpha.-(4-Chlorophenyl)-.alpha.-(1-cyclopropylethyl)-1H-1,2,4-triazole-1-ethanol/CyproconazolePlant protection product94361-06-5
3-(3-(4′-Bromo-(1,1′-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-2-one/3-((RS,3RS;1RS,3SR)-3-(4′-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/DifethialonePlant protection product104653-34-1
Guazatine triacetatePlant protection product115044-19-4
4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/ChlorfenapyrPlant protection product122453-73-0
Aluminium sodium silicate-silver complex/Silver zeolitePlant protection product130328-18-6
Aluminium sodium silicate-silver copper complex/Silver Copper ZeolitePlant protection product130328-19-7
Aluminium sodium silicate-silver zinc complex/Silver-Zinc-ZeolitePlant protection Product130328-20-0
N-Isononyl-N,N-dimethyl-N-decylammonium chloridePlant protection product138698-36-9
N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide/AcetamipridPlant protection product160430-64-8
3-phenoxybenzyl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-PhenothrinPlant protection product188023-86-1
Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 59720-42-2, 16,0 %) and 5-Hydroxy-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS 229-457-6, 28,8 %), and 5-Hydroxypoly[methyleneoxy]methyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 56709-13-8; 5,2 %) in water (50 %)Plant protection product
[1.alpha.(S*),3.alpha.]-(.alpha.)-Cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dichlorovinyl)-2,2-dimenthylcyclopropanecarboxylatePlant protection product
S-CyphenothrinPlant protection product
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS only 1:1)/Bioallethrin/d-trans-AllethrinPlant protection product
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1)/d-AllethrinPlant protection product
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3)/EsbiothrinPlant protection product
Spinosad: fermentation product of soil micro-organism containing Spinosyn A and Spinosyn DPlant protection product
Butoxy polypropylene glycolPolymer9003-13-8
PolydimethylsiloxanePolymer9016-00-6
Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chloridePolymer25988-97-0
Polymer of N,N,N,N-tetramethyl-ethane-1,2-diamine and (chloromethyl)oxiranePolymer25988-98-1
Homopolymer of 2-tert-butylaminoethyl methacrylate (EINECS 223-228-4)Polymer26716-20-1
Polymer of formaldehyde and acroleinPolymer26781-23-7
Monohydro chloride of polymer of N,N‴-1,6-hexanediylbis[N′-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride)Polymer27083-27-8/32289-58-0
Polymer of N,N,N′,N′-tetramethyl-1,6-hexanediamine and 1,6-dichlorohexanePolymer27789-57-7
Poly(hexamethylendimethylammonium chloride)/Poly[(dimethylimino)-1,6-hexanediyl-chloride]Polymer28728-61-2
N,N,N′,N′–Tetramethylethylenediaminebis(2-chloroethyl)ether copolymerPolymer31075-24-8
Poly(hexamethylendiamine guanidinium chloride)Polymer57028-96-3
Poly(hexamethylenebiguanide)Polymer91403-50-8
Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt)Polymer94667-33-1
N,N-Didecyl(-N-methyl-poly(oxyethyl)ammoniumpropionate/1-Decanaminium, N-decyl-N-(2-hydroxyethyl)-N-methyl-, propanoate (salt)Polymer107879-22-1
Copolymer of 2-propenal and propane-1,2-diolPolymer191546-07-3
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium boratePolymer214710-34-6
Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride)Polymer374572-91-5
Tributyltin coPolymer (TBT-coPolymer)Polymer
Fat alcohol polyglycol etherPolymer
Poly(vinyl chloride-co-isobutyl vinyl ether-co-N-vinyl, N′-dimethyl octyl bromide propyl diamine)Polymer
Polyglycolpolyamine resinPolymer
Sodium lignosulfonateNatural Polymer8061-51-6
Neem/Neem-VitalNatural oil5945-86-8
Pinus pumilio oilNatural oil8000-26-8
Cedarwood oilNatural oil8000-27-9
Lavender oilNatural oil8000-28-0
Citronella oilNatural oil8000-29-1
Essential oil of eugenia caryophyllusNatural oil8000-34-8
Geranium oilNatural oil8000-46-2
Eucalyptus OilNatural oil8000-48-4
Orange oilNatural oil8000-57-9
Pine oilNatural oil8002-09-3
Black pepper oilNatural oil8006-82-4
Peppermint oilNatural oil8006-90-4
Lemongrass oilNatural oil8007-02-1
Penny Royal OilNatural oil8007-44-1
Thyme oilNatural oil8007-46-3
Coriander oilNatural oil8008-52-4
Spearmint oilNatural oil8008-75-5
Valeriana officinalis oilNatural oil8008-88-6
Cajuput OilNatural oil8008-98-8
Juniperberry oilNatural oil8012-91-7
Cypress OilNatural oil8013-86-3
Patchouli oilNatural oil8014-09-3
Cumin OilNatural oil8014-13-9
Palmarosa oilNatural oil8014-19-5
Rue oilNatural oil8014-29-7
Basilicum Ocimum basilium oilNatural oil8015-73-4
Bois de rose oil/Rosewood oilNatural oil8015-77-8
Celery oilNatural oil8015-90-5
Chamomile oilNatural oil8015-92-7
Clove leaf oil (Eugenia caryophyllus)Natural oil8015-97-2
Melaleuca oilNatural oil68647-73-4
Litsea cubeba oilNatural oil68855-99-2
Cornmint oilNatural oil68917-18-0
Cedar Oil (Cedarwood oil Texas, Juniperus mexicana oil, 22 %)Natural oil68990-83-0
Citrus extract of seeds of tabebuia avellanedaeNatural oil
Essential oil of cymbopogon winterianusNatural oil
Allium sativum and Allium cepaNatural oil
Essential oil of cinnamomum zeylanicumNatural oil
Clove oil (main components: Eugenol (83,8 %), Caryophyllene (12,4 %), Eugenol acetate (0,4 %))Natural oil
Fir needle perfume oil: (Ethereal oil, main components: Turpentine oil (30-37,5 %), Terpineol (15-20 %), Isobornyl acetate (15-20 %), Pinene beta (12,5-15 %), Pinene alpha (7-10 %), Coumarin (1-3 %), Terpineol-fraction (1-3%)Natural oil
Perfume oil Spring Fresh: ethereal oil: main components: Citral-diethylacetal (Citrathal) (1-3 %), Citronellol (1-3 %), Ylanat (1-3 %), Hivertal (1-3 %), Allylcapronate (1-3 %)Natural oil
Rosas oilNatural oil
Natural PyrethrinsNatural extract
Peat extractNatural extract
Alkyl-benzyl-dimethylammonium chloride/Benzalkonium chlorideMixture8001-54-5
CetrimideMixture8044-71-1
Mixture of 3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8;) and 3,6-acridinediamine/AcriflavineMixture8048-52-0
Mixture of ((3,6-diamino-10-methylacridinium chloride (EINECS 201-668-8) and 3,6-acridinediamine) hydrochloride)/Acriflavine HClMixture8063-24-9
Benzalkonium saccharinate/Benzalkonium o-sulfobenzimidateMixture39387-42-3
Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)Mixture55965-84-9
Siloxanes and Silicones, di-Me, reaction products with silica/Treated Fumed SilicaMixture67762-90-7
Reaction mixture of fatty acids mixed esters (C6-18, derived from coconut oil) with acetic acid and 2,2′-methylenebis(4-chlorophenol)Mixture106523-52-8
Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acidMixture139734-65-9
Quaternary ammonium iodidesMixture308074-50-2
Reaction products of 5,5-dimethylhydantoin and formaldehydeMixture
Reaction products of 2-(2-butoxyethoxy)ethanol and formaldehydeMixture
Reaction products of ethylene glycol and formaldehydeMixture
Reaction products of urea, ethylene glycol and formaldehydeMixture
Reaction products of chloroacetamide, 2(2-butoxyethoxy)ethanol and formaldehydeMixture
Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4)Mixture
Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situMixture
Potassium salts of fatty acids (C15-21)Mixture
Acypetacs copperMixture
Acypetacs zincMixture
Webbing clothes moths pheromone: components: E,Z-Octadecadi-2,13-enal (75 %) and E-Octadec-2-enal (25 %)Mixture
Mixture of chromium trioxide (EINECS 215-607-8; 34,2 %), diarsenic pentoxide (EINECS 215-116-9; 24,1 %), copper(II)oxide (EINECS 215-269-1; 13,7 %), water (EINECS 231-791-2; 28 %)Mixture
Mixture of chlormethylisothiazolinon, ethandiylbisoxybismethanol, methylisothiazolinonMixture
Mixture of bromine (EINECS 231-778-1) and hypobromous acid (CAS-No.: 13517-11-8) manufactured in situMixture
Products of natural fermentation of plants in water, sulphur-containingMixture
Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKCMixture of EINECS listed substances
Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDACMixture of EINECS listed substances
Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMACMixture of EINECS listed substances
Bacillus thuringiensisMicro-organism68038-71-1
Bacillus sphaericusMicro-organism143447-72-7
Bacillus thuringiensis +D381is subsp. IsraelensisMicro-organism
Bacillus thuringiensis Var. KurstakyMicro-organism
Bacillus thuringiensis subsp. Israelensis Serotype H14Micro-organism
Bacillus thuringiensis var. israelensisMicro-organism
Bacillus subtilisMicro-organism
ANNEX II
ACTIVE SUBSTANCES TO BE EXAMINED UNDER THE REVIEW PROGRAMMECovered by Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKC.Covered by Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDAC.Covered by Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMAC.
SubstanceRapporteur Member StateEC numberCAS number1234567891011121314151617181920212223
FormaldehydeDE200-001-850-00-01234569111213202223
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether/Piperonyl butoxideEL200-076-751-03-61819
BronopolES200-143-052-51-712346791011121322
Diphenoxarsin-10-yl oxideFR200-377-358-36-69
ChlorocresolFR200-431-659-50-71234691013
DichlorvosIT200-547-762-73-718
EthanolEL200-578-664-17-51234
Formic acidBE200-579-164-18-61234569111213
Benzoic acidDE200-618-265-85-0123461120
Propan-2-olDE200-661-767-63-01234569101112
Salicylic acidLT200-712-369-72-712346
Propan-1-olDE200-746-971-23-81234
Hydrogen cyanideCZ200-821-674-90-881418
Ethylene oxideN200-849-975-21-8220
1,3-dibromo-5,5-dimethylhydantoinNL201-030-977-48-521112
Citric acidBE201-069-177-92-9123
LinaloolDK201-134-478-70-619
2-chloroacetamideEE201-174-279-07-23679101113
Bromoacetic acidES201-175-879-08-34
Glycollic acidLT201-180-579-14-123412
Peracetic acidFI201-186-879-21-01234561112
L-(+)-lactic acidDE201-196-279-33-4234620
WarfarinIE201-377-681-81-214
(2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one/RotenoneUK201-501-983-79-417
SymcloseneUK201-782-887-90-123456791112
ChloroxylenolBE201-793-888-04-0123456
Biphenyl-2-olES201-993-590-43-712346791013
NaphthaleneUK202-049-591-20-319
DichlorophenIE202-567-197-23-423467910111213
TriclocarbanSK202-924-1101-20-2124
Cinnamaldehyde/3-phenyl-propen-2-alUK203-213-9104-55-22
GeraniolFR203-377-1106-24-11819
GlyoxalFR203-474-9107-22-2234612
m-CresolFR203-577-9108-39-423
Hexa-2,4-dienoic acid/Sorbic acidDE203-768-7110-44-112345678910
GlutaralFI203-856-5111-30-8123456791011121322
Nonanoic acidAT203-931-2112-05-021019
Undecan-2-one/Methyl-nonyl-ketoneES203-937-5112-12-919
PropoxurBE204-043-8114-26-118
1,3-dichloro-5,5-dimethylhydantoinNL204-258-7118-52-521112
CloropheneN204-385-8120-32-112346
Benzyl benzoateUK204-402-9120-51-4218
Benzethonium chlorideBE204-479-9121-54-01
FenitrothionUK204-524-2122-14-518
Cetalkonium chloride204-526-3122-18-9
Benzyldimethyl(octadecyl)ammonium chloride204-527-9122-19-0
2-PhenoxyethanolUK204-589-7122-99-6123467101113
Cetylpyridinium chlorideUK204-593-9123-03-51234567920
Octanoic acidAT204-677-5124-07-2418
Carbon dioxideFR204-696-9124-38-91415181920
Sodium dimethylarsinatePT204-708-2124-65-218
NitromethylidynetrimethanolUK204-769-5126-11-4236111213
Tosylchloramide sodiumES204-854-7127-65-112345691011
Potassium dimethyldithiocarbamateUK204-875-1128-03-0246910111213
Sodium dimethyldithiocarbamateUK204-876-7128-04-123456910111213
Warfarin sodiumIE204-929-4129-06-614
Sodium 2-biphenylateES205-055-6132-27-412346791013
CaptanIT205-087-0133-06-267910
N-(trichloromethylthio)phthalimide/FolpetIT205-088-6133-07-367910
Methyl anthranilateFR205-132-4134-20-319
N,N-diethyl-m-toluamideSE205-149-7134-62-31922
ThiramBE205-286-2137-26-82679101112
ZiramBE205-288-3137-30-42679101112
Potassium methyldithiocarbamateCZ205-292-5137-41-7291112
Metam-sodiumBE205-293-0137-42-8246911121320
Disodium cyanodithiocarbamateCZ205-346-8138-93-2291112
Benzododecinium chloride205-351-5139-07-1
Miristalkonium chloride205-352-0139-08-2
1,3-bis(hydroxymethyl)ureaHU205-444-0140-95-4269111213
NabamPL205-547-0142-59-6246910111213
Lauric acidDE205-582-1143-07-719
ThiabendazoleES205-725-8148-79-8267891011121320
Benzothiazole-2-thiolN205-736-8149-30-4279111213
NaledFR206-098-3300-76-518
DiuronDK206-354-4330-54-16710
DiazinonPT206-373-8333-41-518
Decanoic acidAT206-376-4334-48-541819
CyanamideDE206-992-3420-04-2318
2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-oneSK207-880-7499-44-510
Sodium benzoateDE208-534-8532-32-11261120
DazometBE208-576-7533-74-46789101112
Dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide/TolylfluanidFI211-986-9731-27-1781021
Hydroxyl-2-pyridoneFR212-506-0822-89-926910111213
2,6-dimethyl-1,3-dioxan-4-yl acetateAT212-579-9828-00-226111213
TerbutrynSK212-950-5886-50-07910
DichlofluanidUK214-118-71085-98-9781021
Copper thiocyanateFR214-183-11111-67-721
Tetradonium bromideN214-291-91119-97-71
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-trans-TetramethrinDE214-619-01166-46-718
4,5-dichloro-3H-1,2-dithiol-3-onePL214-754-51192-52-52691112
Diboron trioxideNL215-125-81303-86-28
Calcium dihydroxide/calcium hydroxide/caustic lime/hydrated lime/slaked limeUK215-137-31305-62-023
Calcium oxide/lime/burnt lime/quicklimeUK215-138-91305-78-823
Zinc sulphideUK215-251-31314-98-37910
Copper oxideFR215-269-11317-38-08
Dicopper oxideFR215-270-71317-39-121
Disodium tetraborate, anhydrousNL215-540-41330-43-412789101113
2-Butanone, peroxideHU215-661-21338-23-41236922
MonolinuronUK217-129-51746-81-22
2,4-dichlorobenzyl alcoholCZ217-210-51777-82-82679101213
ChlorothalonilNL217-588-11897-45-667910
FluometuronEL218-500-42164-17-267910111213
4-(2-nitrobutyl)morpholineUK218-748-32224-44-4613
N-(3-aminopropyl)-N-dodecylpropane-1,3-diaminePT219-145-82372-82-9123468910111213
Didecyldimethylammonium bromide219-234-12390-68-3
TolnaftatePL219-266-62398-96-19
2,2′-dithiobis[N-methylbenzamide]PL219-768-52527-58-46791213
1,2-benzisothiazol-3(2H)-oneES220-120-92634-33-526791011121322
2-methyl-2H-isothiazol-3-oneSI220-239-62682-20-4246791011121322
Sulphuryl difluorideSE220-281-52699-79-8818
Troclosene sodiumUK220-767-72893-78-912345691112
Sodium dichloroisocyanurate dihydrateUK220-767-751580-86-012345691112
Mecetronium ethyl sulphatePL221-106-53006-10-812
Bis(trichloromethyl) sulphoneLT221-310-43064-70-86910111222
TriclosanDK222-182-23380-34-512379
Oct-1-ene-3-olN222-226-03391-86-419
(ethylenedioxy)dimethanolPL222-720-63586-55-823469111213
ChlorophacinoneES223-003-03691-35-814
DipyrithioneSE223-024-53696-28-49
Sodium 2,4,6-trichlorophenolateIE223-246-23784-03-02369
Pyridine-2-thiol 1-oxide, sodium saltSE223-296-53811-73-223467910111213
Methenamine 3-chloroallylochloridePL223-805-04080-31-3691213
2,2′,2″-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanolPL225-208-04719-04-423469111213
Tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dioneES226-408-05395-50-62346910111213
Dimethyldioctylammonium chloride226-901-05538-94-3
N,N′-methylenebismorpholineAT227-062-35625-90-1691113
CoumatetralylDK227-424-05836-29-314
TerbuthylazineUK227-637-95915-41-321112
(R)-p-mentha-1,8-dienePT227-813-55989-27-512
Methylene dithiocyanateFR228-652-36317-18-66791011121322
1,3-bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dionePL229-222-86440-58-026111213
(2-bromo-2-nitrovinyl)benzeneSK230-515-87166-19-06111213
Didecyldimethylammonium chlorideIT230-525-27173-51-51234678910111213
Benzyldodecyldimethylammonium bromide230-698-47281-04-1
PrometrynPT230-711-37287-19-667910111213
SilverSE231-131-37440-22-4245911
CopperFR231-159-67440-50-82451121
Sulphur dioxideDE231-195-27446-09-51245691112132022
Calcium dihexa-2,4-dienoateDE231-321-67492-55-91367920
IodineSE231-442-47553-56-212345679101122
Silicon dioxide — amorphousFR231-545-47631-86-931820
Sodium hydrogensulphiteDE231-548-07631-90-51245691112132022
Hydrogen chloride/Hydrochloric acidLV231-595-77647-01-02
Sodium chloridePT231-598-37647-14-55
Sodium bromideNL231-599-97647-15-624679111213
Orthophosphoric acidPT231-633-27664-38-24
Sodium hypochloriteIT231-668-37681-52-91234561112
Disodium disulphiteDE231-673-07681-57-41245691112132022
TetramethrinDE231-711-67696-12-018
Potassium permanganateSK231-760-37722-64-75
Hydrogen peroxideFI231-765-07722-84-11234561112
NitrogenIE231-783-97727-37-918
7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazolePL231-810-47747-35-56111213
Sodium sulphiteDE231-821-47757-83-71245691112132022
Sodium chloritePT231-836-67758-19-22345111220
Copper sulphateFR231-847-67758-98-7124
Silver nitrateSE231-853-97761-88-81
Sodium chloratePT231-887-47775-09-9251112
Disodium peroxodisulphate/Sodium persulphatePT231-892-17775-27-14
Calcium hypochloriteIT231-908-77778-54-31234511
ChlorineIT231-959-57782-50-52511
Ammonium sulphateUK231-984-17783-20-21112
Silver chlorideSE232-033-37783-90-612345679101113
CreosoteSE232-287-58001-58-98
Pyrethrins and PyrethroidsES232-319-88003-34-71819
Garlic ext.PL232-371-18008-99-93451819
LigninEL232-682-29005-53-2123467910111213
Boric acidNL233-139-210043-35-31236789101112131822
Chlorine dioxidePT233-162-810049-04-42345111220
Potassium sulphiteDE233-321-110117-38-11245691112132022
Sodium hydrogen 2,2′methylenebis[4-chlorophenolate]LV233-457-110187-52-723467910111213
2,2-dibromo-2-cyanoacetamideDK233-539-710222-01-21234567910111213
CarbendazimDE234-232-010605-21-767910111213
Disodium octaborate tetrahydrateNL234-541-012280-03-4123678910111213
Trimagnesium diphosphideDE235-023-712057-74-8182023
Copper(II) carbonate-copper(II) hydroxide (1:1)FR235-113-612069-69-18
ZinebIE235-180-112122-67-721
Ammonium bromideSE235-183-812124-97-9246791112
Hexaboron dizinc undecaoxide/Zinc borateES235-804-212767-90-79
Pyrithione zincSE236-671-313463-41-72679101321
Dodecylguanidine monohydrochlorideES237-030-013590-97-11267910111222
Potassium 2-biphenylateES237-243-913707-65-8691013
Bromine chlorideNL237-601-413863-41-721112
(benzyloxy)methanolUK238-588-814548-60-8269101113
Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copperSE238-984-014915-37-8921
ChlorotoluronES239-592-215545-48-967910111213
Sodium p-chloro-m-cresolateFR239-825-815733-22-91234691013
ChloralosePT240-016-715879-93-3141523
Dipotassium disulphiteDE240-795-316731-55-81245691112132022
D-gluconic acid, compound with N,N″-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediamidine (2:1)PT242-354-018472-51-012346
Benzoxonium chlorideCY243-008-119379-90-919
p-[(diiodomethyl)sulphonyl]tolueneUK243-468-320018-09-1679101213
Copper dihydroxideFR243-815-920427-59-28
Disilver oxideSE243-957-120667-12-311
Aluminium phosphideDE244-088-020859-73-814182023
(benzothiazol-2-ylthio)methyl thiocyanateN244-445-021564-17-02467910111213
BendiocarbUK245-216-822781-23-318
2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/PrallethrinEL245-387-923031-36-918
Potassium (E,E)-hexa-2,4-dienoateDE246-376-124634-61-512345678910
.alpha.,.alpha.′,.alpha.″-trimethyl-1,3,5-triazine-1,3,5(2H,4H,6H)-triethanolAT246-764-025254-50-62691113
2-octyl-2H-isothiazol-3-oneUK247-761-726530-20-1467910111213
Cis-tricos-9-eneAT248-505-727519-02-41819
Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chlorideES248-595-827668-52-627910
N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamineNL248-872-328159-98-0791021
3-[3-(4′-bromo[1,1′-biphenyl]-4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy-2-benzopyrone/BromadioloneSE249-205-928772-56-714
(Z,E)-tetradeca-9,12-dienyl acetateAT250-753-630507-70-1819
Decyldimethyloctylammonium chloride251-035-532426-11-2
Bromochloro-5,5-dimethylimidazolidine-2,4-dioneNL251-171-532718-18-6234569111213
3-(4-isopropylphenyl)-1,1-dimethylurea/IsoproturonDE251-835-434123-59-667910111213
N-[[(4-chlorophenyl)amino]carbonyl]-2,6-difluorobenzamideSE252-529-335367-38-518
1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole/ImazalilDE252-615-035554-44-02341320
S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate/AzamethiphosUK252-626-035575-96-318
2-bromo-2-(bromomethyl)pentanedinitrileCZ252-681-035691-65-7679101113
Benzyldimethyloleylammonium chloride253-363-437139-99-4
Calcium magnesium oxide/dolomitic limeUK253-425-037247-91-923
Calcium magnesium tetrahydroxide/calcium magnesium hydroxide/hydrated dolomitic limeUK254-454-139445-23-323
.alpha.-cyano-3-phenoxybenzyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylateEL254-484-539515-40-718
Dimethyltetradecyl[3-(trimethoxysilyl)propyl]ammonium chloridePL255-451-841591-87-19
Mixture of cis- and trans-p-menthane-3,8 diol/CitriodiolUK255-953-742822-86-61219
4,4-dimethyloxazolidineUK257-048-251200-87-46111213
ethyl N-acetyl-N-butyl-.beta.-alaninateBE257-835-052304-36-619
.alpha.-cyano-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/CypermethrinBE257-842-952315-07-88918
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/PermethrinIE258-067-952645-53-1235891822
.alpha.-cyano-3-phenoxybenzyl [1R-[1.alpha.(S*),3.alpha.]]-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate/DeltamethrinSE258-256-652918-63-518
1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/EmpenthrinBE259-154-454406-48-318
3-iodo-2-propynyl butylcarbamateDK259-627-555406-53-66789101113
Tetrakis(hydroxymethyl)phosphonium sulphate(2:1)MT259-709-055566-30-82691112
3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin/DifenacoumFI259-978-456073-07-514
4-hydroxy-3-(3-(4′-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin/BrodifacoumIT259-980-556073-10-014
1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole/PropiconazoleFI262-104-460207-90-112478910121320
Quaternary ammonium compounds, coco alkyltrimethyl, chlorides263-038-961789-18-2
Quaternary ammonium compounds, benzylcoco alkyldimethyl, chlorides263-080-861789-71-7
Quaternary ammonium compounds, dicocoalkyl dimethyl, chlorides263-087-661789-77-3
Quaternary ammonium compounds, bis(hydrogenated tallow alkyl)dimethyl, chlorides263-090-261789-80-8
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides264-151-663449-41-2
4,5-dichloro-2-octyl-2H-isothiazol-3-oneN264-843-864359-81-5678910111221
2-chloro-N-[[[4-(trifluoromethoxy)phenyl]amino]carbonyl]benzamideIT264-980-364628-44-018
3,3′-methylenebis[5-methyloxazolidine]/OxazolidinAT266-235-866204-44-22610111213
N-cyclopropyl-1,3,5-triazine-2,4,6-triamineEL266-257-866215-27-818
Cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine/FenpropimorphES266-719-967564-91-46789101213
.alpha.-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/CyfluthrinDE269-855-768359-37-518
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, chloridesIT269-919-468391-01-512345679101112131722
Quaternary ammonium compounds, di-C6-12-alkyldimethyl, chlorides269-925-768391-06-0
Quaternary ammonium compounds, benzyl-C8-16-alkyldimethyl, chlorides270-324-768424-84-0
Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chloridesIT270-325-268424-85-11234678910111213
Quaternary ammonium compounds, di-C8-10-alkyldimethyl, chloridesIT270-331-568424-95-3123456791011121322
Fatty acids, coco, reaction products with diethanolamineHU270-430-368440-04-03
Quaternary ammonium compounds, benzyl-C10-16-alkyldimethyl, chlorides273-544-168989-00-4
Quaternary ammonium compounds, benzyl-C12-18-alkyldimethyl, salts with 1,2-benzisothiazol-3(2H)-one 1,1-dioxide (1:1)MT273-545-768989-01-5241112
Sodium N-(hydroxymethyl)glycinateAT274-357-870161-44-367
Amines, C10-16-alkyldimethyl, N-oxidesPT274-687-270592-80-212
Pentapotassium bis(peroxymonosulphate) bis(sulphate)SI274-778-770693-62-8123451112
N,N′-(decane-1,10-diyldi-1(4H)-pyridyl-4-ylidene)bis(octylammonium) dichlorideHU274-861-870775-75-61
1,3-didecyl-2-methyl-1H-imidazolium chlorideCZ274-948-070862-65-62346710111213
ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate/FenoxycarbDE276-696-772490-01-88
Quaternary ammonium compounds, di-C8-18-alkyldimethyl, chlorides277-453-873398-64-8
1-[1,3-bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea/DiazolidinylureaLT278-928-278491-02-867
Dihydrogen bis[monoperoxyphthalato(2-)-O1,OO1]magnesate(2-) hexahydratePL114915-85-4234
Tributyltetradecylphosphonium chloridePL279-808-281741-28-82491112
Margosa ext.DE283-644-784696-25-31819
Tar acids, polyalkylphenol fractionHU284-893-484989-05-923
Melaleuca alternifolia, ext./Australian Tea Tree OilES285-377-185085-48-9123
Quaternary ammonium compounds, benzyl-C12-14-alkyldimethyl, chloridesIT287-089-185409-22-912345679101112131722
Quaternary ammonium compounds, C12-14-alkyl[(ethylphenyl)methyl]dimethyl, chloridesIT287-090-785409-23-012345691112131722
Chrysanthemum cinerariaefolium, ext.ES289-699-389997-63-718
Urea, N,N′-bis(hydroxymethyl)-, reaction products with 2-(2-butoxyethoxy)ethanol, ethylene glycol and formaldehydePL292-348-790604-54-926111213
Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, bromides293-522-591080-29-4
Lavender, Lavandula hybrida, ext./Lavandin oilPT294-470-691722-69-919
Pine ext.LV304-455-994266-48-510
Quaternary ammonium compounds, [2-[[2-[(2-carboxyethyl)(2-hydroxyethyl)amino]ethyl]amino]-2-oxoethyl]coco alkyldimethyl, hydroxides, inner saltsLT309-206-8100085-64-112346710111213
Corn cob, powderedEL310-127-6999999-99-414
1-(3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)phenyl)-3-(2,6-difluorobenzoyl)urea/HexaflumuronPT401-400-186479-06-318
1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dioneNL401-570-789415-87-221112
1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol/TebuconazoleDK403-640-2107534-96-378910
Reaction products of: glutamic acid and N-(C12-14-alkyl)propylenediamineDE403-950-8164907-72-61234
Mixture of: (C8-18)alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate;(C8-18)alkylbis(2-hydroxyethyl)ammonium 2-ethylhexylhydrogenphosphatePL404-690-868132-19-4679
2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate/TransfluthrinNL405-060-5118712-89-318
5,5-dimethyl-perhydro-pyrimidin-2-one .alpha.-(4-trifluoromethylstyryl)-.alpha.-(4-trifluoromethyl)cinnamylidenehydrazone/HydramethylnonIE405-090-967485-29-418
3-phenoxybenzyl-2-(4-ethoxyphenyl)-2-methylpropylether/EtofenproxAT407-980-280844-07-123818
6-(phthalimido)peroxyhexanoic acidIT410-850-8128275-31-012341112
Methyl neodecanamideES414-460-9105726-67-819
Mixture of: alpha-cyano-3-phenoxybenzyl (Z)-(1R,3R)-[(S)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate;alpha-cyano-3-phenoxybenzyl (Z)-(1S,3S)-[(R)-3-(2-chloro-3,3,3-trifluoro-prop-1-enyl)]-2,2-dimethylcyclopropanecarboxylate/Lambda cyhalothrinSE415-130-791465-08-618
1-(4-(2-cloro-a,a,a-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea/FlufenoxuronFR417-680-3101463-69-8818
2-butyl-benzo[d]isothiazol-3-oneCZ420-590-74299-07-46791013
Tetrachlorodecaoxide complexDE420-970-292047-76-212345
Mixture of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin; trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin/FlocoumafenNL421-960-090035-08-814
sec-butyl 2-(2-hydroxyethyl)piperidine-1-carboxylate/IcaridineDK423-210-8119515-38-719
FipronilFR424-610-5120068-37-318
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloridePL426-020-351229-78-8691213
1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine/ImidaclopridDE428-040-8138261-41-318
ThiamethoxamES428-650-4153719-23-48918
[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;[2,4-Dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate/ImiprothrinUK428-790-672963-72-518
5-chloro-2-(4-chlorphenoxy)phenolAT429-290-03380-30-112469
2-(1-methyl-2-(4-phenoxy-phenoxy)-ethoxy)-pyridine/PyriproxyfenNL429-800-195737-68-118
3-benzo(b)thien-2-yl-5,6-dihydro-1,4,2-oxathiazine,4-oxidePT431-030-6163269-30-546791013
Reaction products of diisopropanolamine with formaldehyde(1:4)HU432-440-8220444-73-5613
Reaction product of dimethyl adipate, dimethyl glutarate, dimethyl succinate with hydrogen peroxide/PerestaneHU432-790-1-123451112
Bis(3-aminopropyl)octylamineCZ433-340-786423-37-2234111213
(E)-1-(2-Chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine/ChlothianidinDE433-460-1210880-92-53818
Peroxyoctanoic acidFR33734-57-52341112
Cyclohexylhydroxydiazene 1-oxide, potassium saltAT66603-10-9678910111213
Bis[1-cyclohexyl-1,2-di(hydroxy-.kappa.O)diazeniumato(2-)]-copperAT312600-89-826789101112
Silver zeolite ASE-24579
Bacillus sphaericusITMicro-organism143447-72-7218
Bacillus thuringiensis subsp. Israelensis Serotype H14ITMicro-organism-2518
Bacillus subtilisDEMicro-organism-3
Alkyl-benzyl-dimethylammonium chloride/Benzalkonium chlorideMixture8001-54-5
Mixture of 5-chloro-2-methyl-2H-isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)FRMixture55965-84-923467910111213
Amines, n-C10-16-alkyltrimethylenedi-, reaction products with chloroacetic acidIEMixture139734-65-912346710111213
Quaternary ammonium iodidesESMixture308074-50-21234567
Mixture of 1-phenoxypropan-2-ol (EINECS 212-222-7) and 2-phenoxypropanol (EINECS 224-027-4)UKMixture-12346101113
Active Chlorine: manufactured by the reaction of hypochlorous acid and sodium hypochlorite produced in situSKMixture-2345
Potassium salts of fatty acids (C15-21)DEMixture-2
Quaternary ammonium compounds (benzylalkyldimethyl (alkyl from C8-C22, saturated and unsaturated, tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or hydroxides)/BKCITMixture of EINECS listed substances-1234678910111213
Quaternary ammonium compounds (dialkyldimethyl (alkyl from C6-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/DDACITMixture of EINECS listed substances-1234678910111213
Quaternary ammonium compounds (alkyltrimethyl (alkyl from C8-C18, saturated and unsaturated, and tallow alkyl, coco alkyl, and soya alkyl) chlorides, bromides, or methylsulphates)/TMACITMixture of EINECS listed substances-8
Sodium lignosulfonateHUNatural Polymer8061-51-612
Silver-zinc-aluminium-boronphosphate glass/Glass oxide, silver- and zinc-containingSENot yet allocated398477-47-912679
Silver sodium hydrogen zirconium phosphateSENot yet allocated-12347910
(±)-1-(.beta.-allyloxy-2,4-dichlorophenylethyl)imidazole/Technical grade imazalilDEPlant protection product73790-28-023413
Silicium dioxide/KieselguhrFRPlant protection product61790-53-218
S-Methoprene/Isopropyl (s-(E,E))-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoateIEPlant protection product65733-16-618
Esfenvalerate/(S)-.alpha.-Cyano-3-phenoxybenzyl (S)-2-(4-chlorophenyl)-3-methylbutyratePTPlant protection product66230-04-418
[1.alpha.(S*),3.alpha.]-(.alpha.)-cyano-(3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2.2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate/alpha-CypermethrinBEPlant protection product67375-30-86918
Abamectin (Mixture of Avermectin B1a; > 80 %, EINECS 265-610-3; and Avermectin B1b; < 20 % EINECS 265-611-9)NL265-610-371751-41-218
Cyclopropanecarboxylic acid, 3-[(1Z)-2-chloro-3,3,3-trifluoro-1-propenyl]-2,2-dimethyl-, (2-methyl[1,1′-biphenyl]-3-ylmethyl ester, (1R,3R)-rel-/Bifenthrin/BiphenateFRPlant protection product82657-04-3818
.alpha.-(4-Chlorophenyl)-.alpha.-(1-cyclopropylethyl)-1H-1,2,4-triazole-1-ethanol/CyproconazoleIEPlant protection product94361-06-58
3-(3-(4′-Bromo-(1,1′-biphenyl)-4-yl)-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxybenzothiopyran-2-one/3-((RS,3RS;1RS,3SR)-3-(4′-bromobiphenyl-4-yl-1,2,3,4-tetrahydro-1-napthyl)-4-hydroxy-1-benzothin-2-one/DifethialoneNPlant protection product104653-34-114
Guazatine triacetateUKPlant protection product115044-19-42
4-Bromo-2-(4-chlorophenyl)-1-(ethoxymethyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile/ChlorfenapyrPTPlant protection product122453-73-0678910121318
Aluminium sodium silicate-silver complex/Silver zeoliteSEPlant protection product130328-18-66713
Aluminium sodium silicate-silver zinc complex/Silver-Zinc-ZeoliteSEPlant protection Product130328-20-012679
N-((6-Chloro-3-pyridinyl)methyl)-N′-cyano-N-methylethanimidamide/AcetamipridBEPlant protection product160430-64-818
3-phenoxybenzyl (1R)-cis,trans-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate/d-PhenothrinIEPlant protection product188023-86-118
Mixture of 5-Hydroxymethoxymethyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 59720-42-2, 16,0 %) and 5-Hydroxy-1-aza-3,7-dioxabicyclo(3.3.0)octane (EINECS 229-457-6, 28,8 %), and 5-Hydroxypoly[methyleneoxy]methyl-1-aza-3,7-dioxabicyclo(3.3.0)octane (CAS 56709-13-8; 5,2 %) in water (50 %)PLPlant protection product-613
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers: 1R trans: 1RS only 1:1)/Bioallethrin/d-trans-AllethrinDEPlant protection product-18
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 4 isomers 1R trans, 1R: 1R trans, 1S: 1R cis, 1R: 1R cis, 1S 4:4:1:1)/d-AllethrinDEPlant protection product-18
(RS)-3-Allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)-cyclopropanecarboxylate (mixture of 2 isomers 1R trans: 1R/S only 1:3)/EsbiothrinDEPlant protection product-18
Spinosad: fermentation product of soil micro-organisms containing Spinosyn A and Spinosyn DNLPlant protection product-318
Polyvinylpyrrolidone iodineSEPolymer25655-41-812345679101122
Polymer of N-Methylmethanamine (EINECS 204-697-4 with (chloromethyl)oxirane (EINECS 203-439-8)/Polymeric quaternary ammonium chlorideHUPolymer25988-97-021112
Polymer of formaldehyde and acroleinHUPolymer26781-23-73
Monohydro chloride of polymer of N,N′′′-1,6-hexanediylbis[N′-cyanoguanidine] (EINECS 240-032-4) and hexamethylenediamine (EINECS 204-679-6)/Polyhexamethylene biguanide (monomer: 1,5-bis(trimethylen)-guanylguanidinium monohydrochloride)FRPolymer27083-27-8/32289-58-01234569111222
N,N,N′,N′–Tetramethylethylenediaminebis(2-chloroethyl)ether copolymerUKPolymer31075-24-829111213
Poly(hexamethylendiamine guanidinium chloride)FRPolymer57028-96-3123456791011121320
Poly(hexamethylenebiguanide)FRPolymer91403-50-8123491011
Poly(oxy-1,2-ethanediyl), .alpha.-[2-(didecylmethylammonio)ethyl]- .omega.-hydroxy-, propanoate (salt)ITPolymer94667-33-123468910111213
Copolymer of 2-propenal and propane-1,2-diolHUPolymer191546-07-3671013
N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borateELPolymer214710-34-6268910111213
Oligo(2-(2-ethoxy)ethoxyethylguanidinium chloride)FRPolymer374572-91-5123456791011121320
ANNEX IIIRequirements for the complete dossier and the summary dossier(a)The complete dossier must include the original test and study reports for each point of Annex IIA and IIB, or Annex IVA and IVB, to Directive 98/8/EC, and where specified the relevant parts of Annex IIIA and IIIB thereto, together with the summary dossier referred to in Article 11(1)(b) of that Directive.(b)The summary dossier must include the following:in the case of a collective dossier, the name of all participants concerned and a person designated by them as being responsible for the collective dossier and the processing of the dossier in accordance with this Regulation,for each point of Annex IIA and IIB, or Annex IVA and IVB, to Directive 98/8/EC, and where specified the relevant parts of Annex IIIA and IIIB to the Directive, the summaries and results of studies and trials,list of references used,risk assessment,overall summary and assessment,a check by the participant or, where appropriate, by the person designated as responsible for a collective dossier of the completeness of the dossier.(c)The formats made available by the Commission must be used for submission of the dossiers. In addition, the special software package (IUCLID) made available by the Commission must be used for those parts of the dossiers to which IUCLID applies. Formats and further guidance on data requirements and dossier preparation are available on the ECB homepage http://ecb.jrc.it/biocides(d)For existing active substances that have been or are being evaluated under the review programme for plant protection products in accordance with Article 8(2) of Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the marketOJ L 230, 19.8.1991, p. 1., the required format for an application for inclusion in Annex I thereto may be used for the preparation of the dossier for inclusion of the existing active substance in Annex I, IA or IB to Directive 98/8/EC, taking into account relevant differences in the dossier requirements. A summary of the dossier must be entered in IUCLID. Additional information related to the biocidal use must be submitted in accordance with the requirements of this Regulation.
Loading ...